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Maternal deaths in Australia 2008–2012 is the 16th report 
on women who die in association with pregnancy and 
childbirth. Maternal death review is one of the oldest  
known forms of clinical care quality assurance. Maternal 
death in Australia is a rare event in the context of worldwide 
maternal deaths. In 2008–2012, there were 105 maternal 
deaths in Australia that occurred within 42 days of the 
end of pregnancy, representing a maternal mortality ratio 
(MMR) of 7.1 deaths per 100,000 women who gave birth. 
All such deaths should be seen as devastating for the 
woman’s family and community, and should be carefully 
examined for possible lessons learned that may prevent 
future similar events.
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Summary 
Maternal deaths in Australia 2008–2012 provides a summary of statistics on maternal mortality 
in Australia to inform safety and quality of maternity care in Australia, and provides good 
practice guidance from members of the National Maternal Mortality Advisory Committee 
(NMMAC).  
In 2008–2012, there were 105 maternal deaths in Australia that occurred within 42 days of the 
end of pregnancy, representing a maternal mortality ratio (MMR) of 7.1 deaths per 100,000 
women who gave birth in Australia. The number of maternal deaths increased each year 
from 2008 to 2012. It is uncertain whether this is an actual increase or reflects improvements 
in case ascertainment.  
There were 49 maternal deaths directly related to the pregnancy in 2008–2012. Fifty-three 
deaths were indirect maternal deaths, due to non-pregnancy related conditions aggravated 
by the pregnancy or its management. Three maternal deaths could not be classified as direct 
or indirect deaths.  
The women who died were aged between 17 and 50. Women aged 40 and over, women who 
are obese with a body mass index (BMI) of 30 or more, and women of Aboriginal and Torres 
Strait Islander origin, were among those at increased risk of maternal death.  
Maternal mortality in Australia has been reported since the 1964–1966 triennium. The direct 
MMR in the 1964–1966 triennium (30.3 deaths per 100,000 women who gave birth) was 10.4 
times higher than the direct MMR in the 2009–2011 triennium (2.9 deaths per 100,000 women 
who gave birth). The total MMR has fallen from 12.7 deaths per 100,000 women who gave 
birth in 1973–1975 to 7.2 deaths per 100,000 women who gave birth in 2009–2011. 
Key causes of maternal death in Australia in 2008–2012 
• The leading causes of direct maternal death were obstetric haemorrhage (11), 
thromboembolism (10) and hypertensive disorders (9) and, when combined, these 
accounted for more than 61% of all direct maternal deaths.  
• The leading cause of indirect maternal death was cardiovascular disease (15).  
• There were 16 deaths due to psychosocial causes, including 12 due to suicide.  
• Five of the direct deaths due to obstetric haemorrhage were related to the presence of 
pathological placentation (placenta accreta and/or percreta), and 5 were due to 
postpartum haemorrhage. 
• Five non-obstetric haemorrhage deaths resulted from rupture of a splenic artery 
aneurysm and 5 were due to intracranial haemorrhage. 
Aboriginal and Torres Strait Islander maternal mortality 
Maternal mortality for Aboriginal and Torres Strait Islander women is double that of other 
Australian women, with an Aboriginal and Torres Strait Islander MMR of 13.8 deaths per 
100,000 women who gave birth compared with 6.6 deaths per 100,000 for other Australian 
women who gave birth. Although the differential between the MMRs is decreasing, caution 
should be exercised in drawing conclusions due to the small numbers being analysed. 
Cardiovascular conditions, sepsis and psychosocial conditions were the leading causes of 
maternal deaths among Aboriginal and Torres Strait Islander women. 
  Maternal deaths in Australia 2008–2012 1 
1 Introduction 
1.1 Background to the report 
Although maternal death and pregnancy-related morbidity are rare in Australia, the review 
of maternal deaths remains an important measure of maternity services and obstetric care. 
This is the sixteenth report published on maternal deaths in Australia. The purpose of the 
report is to identify trends in maternal mortality and to develop an evidence base for 
maternal deaths that can be used to inform maternity services policy and practice. Since 
Australia initiated the practice of reporting and subsequently published data on maternal 
mortality for the triennium 1964–1966, maternal deaths have decreased by nearly two-thirds.  
The World Health Organization (WHO) estimates that worldwide 287,000 women die each 
year from complications of pregnancy and childbirth (WHO 2014). Australia is a signatory to 
the United Nations Millennium Development Goals (MDGs), which form an agreed 
international blueprint aimed at reducing poverty, hunger and disease by the target date of 
2015. The fifth MDG is ‘Improve maternal health’, and is stated as ‘Reduce by three-quarters, 
between 1990 and 2015, the maternal mortality ratio’ (UN 2010). The maternal mortality ratio 
has dropped by 45% between 1990 and 2013, from 380 to 210 deaths per 100,000 live births 
<http://www.who.int/mediacentre/factsheets/fs348/en/>. 
The National Maternity Services Plan 
In 2008, a national review of maternity services was carried out in Australia, led by the 
Commonwealth Chief Nurse and Midwifery Officer. The findings were presented in 2009 in 
Improving maternity services in Australia: the report of the Maternity Services Review 
(Commonwealth of Australia 2009). The report aimed to identify key gaps in maternity care 
and to inform development of the first National Maternity Services Plan (AHMC 2011). 
The National Maternity Services Plan (the Plan) was launched in February 2011 and sets out 
a 5-year vision for maternity care that provides a strategic national framework to guide 
policy and program development across Australia (AHMC 2011). 
The purpose of the Plan is to maintain Australia’s high standard of maternity care while 
seeking to improve access to services and choice in care, which includes increasing and 
supporting the maternity workforce, strengthening infrastructure and building the evidence 
base of what works well in Australia. In particular, the Plan’s priority areas are to: meet the 
needs of women and their families living in rural and remote areas; improve birth outcomes 
for Aboriginal and Torres Strait Islander people; and meet the requirements of women who 
are vulnerable due to medical or other risk factors. The Plan targets primary maternity 
services during the antenatal, intrapartum and 6-week postnatal period for both women and 
babies (AHMC 2011). In 2011, the incumbent federal government provided funding for the 
National Maternity Data Development Project (NMDDP). 
National Maternity Data Development Project 
The NMDDP was set up in response to Recommendation 1 of the Plan. The primary aims of 
the NMDDP are to develop a nationally consistent and comprehensive maternal and 
perinatal mortality and morbidity data collection in Australia. High-quality and nationally 
consistent data are required to assess the safety and outcomes of current and emerging 
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models of maternity care in Australia and will enable the monitoring of disparities in health 
outcomes for population subgroups compared with the general population. The project is 
managed by the NMDDP Advisory Group. A report on Stage 1 of the NMDDP was 
published in 2014 (see <http://www.aihw.gov.au/publication-detail/?id=60129547184>).  
National Maternal Mortality Advisory Committee  
The NMMAC was convened to provide guidance and national relevance to the development 
of the national Maternal deaths in Australia reports (the current members are listed in 
Appendix A), and is a subcommittee of the NMDDP Advisory Group. The NMMAC 
provides expert advice on the development of Maternal deaths in Australia reports, including 
strategic advice, facilitation of data supply and provision of clinical commentary, and good 
practice guidance.  
1.2 Purpose of this report 
The National Maternity Services Plan Priority Action 2.1 recommends that a national 
maternal mortality review process be established and that national maternal mortality 
reports are produced (AHMC 2011). This report reviews 5 years of maternal deaths, from 
2008 to 2012, and is a ‘rolling’ quinquennial report, building from the Maternal deaths in 
Australia 2006–2010 report.  
Detailed examination and reporting of maternal deaths improves performance in all sectors 
of maternity care by advancing maternity care practices and informing policy. 
Internationally, measuring maternal mortality enables comparisons of maternal health 
outcomes across countries, and may be seen as an indicator of society’s health-care services. 
Where possible, comparisons are made with data contained in the most recent maternal 
mortality reports from New Zealand (PMMRC 2014) and United Kingdom (Knight et al. 
2014) data. Relevant studies by Australasian Maternity Outcomes Surveillance System 
(AMOSS) and UK Obstetric Surveillance System (UKOSS), where published, are also 
referenced. 
1.3 Aims of this report 
• Provide an overview of maternal mortality from collated information on maternal deaths 
in Australia that occurred during the period 1 January 2008 to 31 December 2012. 
• Provide an evidence base to inform policy development. 
• Provide a platform to assist practitioners to reduce maternal mortality and counsel high-
risk women who are considering pregnancy.  
• Provide guidance regarding women who may be at higher than normal risk of death or 
severe morbidity and who may require additional care efforts in relation to those 
identified risk factors. 
• Inform national processes for classification of maternal deaths, providing a basis for 
consensus in the review of maternal deaths by state and territory maternal mortality 
committees (STMMCs), and nationally. 
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1.4 Structure of this report 
Chapter 1 provides the background, including the policy context. 
Chapter 2 provides the definitions and classifications used in the report, and the 
methodology and data used in measuring maternal mortality. 
Chapter 3 provides an overview of maternal deaths in Australia from 2008 to 2012. 
Chapter 4 provides detailed information on causes of direct and indirect maternal deaths. 
Chapter 5 provides detailed information on maternal deaths of Aboriginal and Torres Strait 
Islander women. 
Chapter 6 provides information on incidental maternal deaths. 
The report includes illustrative case vignettes and good-practice guidance points to make the 
report more accessible to clinicians working in maternity services. The aim of these sections 
is to provide educational opportunities for teaching and learning and practice improvement. 
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2 Definitions, classification and methods 
2.1 Definitions and classifications 
Australia applies the standard international definition of ‘maternal death’. The WHO 
International statistical classification of diseases and related health problems, 10th revision (ICD-10), 
defines maternal death as ‘the death of a woman while pregnant or within 42 days of 
termination of pregnancy, irrespective of the duration and the site of the pregnancy, from 
any cause related to or aggravated by the pregnancy or its management, but not from 
accidental or incidental causes’ (WHO 1992). Maternal deaths are subdivided into 2 
categories: direct and indirect deaths (Table 2.1). These categories divide the maternal deaths 
into those that result directly from complications of pregnancy or its management (direct), 
and those that are due to pre-existing or inter-current disease but where disease progression 
was influenced by pregnancy (indirect). Deaths considered to be unrelated to pregnancy are 
classified as ‘incidental’.  
Table 2.1: Definitions of maternal death categories 
Type of death Definition 
Direct maternal deaths(a) Those resulting from obstetric complications of the pregnant state (pregnancy, labour and 
puerperium) from interventions, omissions, incorrect treatment or from a chain of events 
resulting from any of the above 
Indirect maternal deaths(a)  Those resulting from previous existing diseases or diseases that developed during 
pregnancy, and which were not due to a direct obstetric cause, but were aggravated by the 
physiologic effects of pregnancy 
Incidental maternal deaths Deaths from unrelated causes that happen to occur in pregnancy or the puerperium 
Maternal death, not further 
classified 
Deaths considered to be related to the pregnancy or its management, but could not be 
further classified as either ‘direct’ or ‘indirect’ 
Unclassified death Maternal death from unspecified or undetermined cause occurring during pregnancy, labour 
and delivery, or the puerperium 
(a) Definitions are from the International statistical classification of diseases and related health problems, 10th revision, volume 2, section 5.8.1.  
The category ‘Maternal death, not further classified’ was applied where pregnancy was 
considered to have contributed to the death, but where the jurisdictional maternal mortality 
committee found that the death could not be classified as a direct or indirect maternal death.  
Deaths that were not classified by state or territory and were provided with insufficient 
information to assess cause of death were considered ‘unclassifiable’.  
Though there is increasing interest in the examination of ‘Late maternal deaths’ in a number 
of jurisdictions (Knight et al. 2014; QMPQC 2013), they are not examined in this report. Late 
maternal deaths are deaths that occur between 43 days and 365 days after pregnancy ends 
and result from obstetric complications of the pregnant state or previous existing diseases or 
diseases that developed during pregnancy. 
The cause of death used in this maternal mortality report is that determined by the STMMC 
after consideration of all available information. Autopsy, coronial and other information is 
frequently available after the health-care facility admission and discharge coding process is 
completed, and hence the cause of death allocated by the STMMC may not be the same as 
the initial discharge ICD-10 coding.  
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Classification of deaths related to psychosocial morbidity 
In 2011 and 2012, the World Health Organization (WHO) recommended classifying all 
maternal suicide deaths as direct maternal deaths (Pattinson et al. 2009; WHO 2012).  
In Australia, the process of classification has been dependent on whether there is a known 
history of psychiatric illness. Jurisdictional maternal mortality committees (STMMC) have 
usually classified a death where there was previous psychiatric illness that was known to 
health-care professionals as an indirect death unless a new mental health illness arose for the 
first time during the pregnancy, in which case it would be classified as a direct death. 
Maternal deaths associated with external events, such as homicide, substance abuse and 
events of undetermined intent, would be classified as either an indirect or incidental death, 
depending on the presenting circumstances. 
However, in 2012 the NMMAC considered the classification of psychosocial maternal deaths 
and took advice from the Royal Australian and New Zealand College of Psychiatrists 
(RANZCP) and from within its expert membership. RANZCP’s view is that it is difficult to 
determine the onset of psychosocial issues and, if a significant psychiatric issue arises during 
pregnancy or postpartum, it is still a psychiatric issue and therefore it should always be 
classified as an indirect cause if maternal death occurs.  
The NMMAC came to the conclusion that puerperal psychosis, which is related to a dramatic 
change in hormone levels during pregnancy, is extremely rare and is the only mental health 
condition known to be directly related to pregnancy. Hence, maternal deaths related to the 
development of a puerperal psychosis are the only psychosocial maternal deaths that are 
directly related to the pregnancy. Maternal deaths related to underlying psychiatric illness 
are only indirectly related to the physiological effects of pregnancy. It was further agreed to 
classify relevant external causes of maternal death (such as substance misuse, homicide in 
the setting of domestic violence and events of undetermined intent) to ‘indirect’ causes of 
death. Homicide occurring in a setting other than a psychosocial setting such as domestic 
violence is classified as ‘incidental’ death. 
Note: Because this decision was made by the NMMAC at the end of 2012, some of the deaths 
in this report were classified by the relevant STMMC using previous classification 
conventions. Therefore, categorisation of psychosocial deaths into direct, indirect and 
incidental may not be consistent within this report and with previous reporting periods.  
2.2 Measuring maternal mortality 
A maternal death is the death of a woman while pregnant or within 42 days of termination of 
pregnancy, irrespective of the duration and the site of the pregnancy, from any cause related 
to or aggravated by the pregnancy or its management, but not from accidental or incidental 
causes (WHO 1992). 
The incidence of maternal death is expressed as the maternal mortality ratio (MMR), which is 
calculated using direct and indirect deaths combined, and excludes incidental deaths. 
The WHO definition specifies that the number of live births or the total number of births 
(live births plus fetal deaths) can be used as the denominator, and where both denominators 
are available, both calculations are made (WHO 1992). Although the most appropriate 
denominator for estimating maternal mortality would be the number of women at risk (that 
is, the number of pregnant or recently pregnant women), this number is not available in 
Australia because the number of pregnancies ending before 20 weeks gestation is unknown. 
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In Australia, accurate population data are available for the number of women who gave birth 
to at least 1 baby (either a live birth or a stillbirth) of 20 weeks completed gestation or more 
or birthweight of 400 grams or more; this is the denominator number used when calculating 
the MMR in this report.  
Calculation of maternal mortality ratio (MMR) 
MMR = Number of direct and indirect maternal deaths(a)
Number of women who gave birth(a)
× 100,000 
(a) For a defined place and time. 
Australian maternal death reports prior to the 1997–1999 triennium included incidental 
deaths in the definition and MMR calculations. Caution must therefore be taken when 
comparing MMRs from triennia prior to 1997–1999 with MMRs from the 1997–1999 
triennium onwards. Refer to Table 3.2 for comparable rates that separate out the components 
of direct, indirect and incidental deaths for these years. 
2.3 Data for 2008–2012 maternal deaths 
Primary data collection and review regarding maternal deaths in Australia is undertaken by 
the state and territory health departments, with initial notification including significant input 
from the relevant Registrars of Births, Deaths and Marriages, and Coroners. Data from these 
jurisdictions are subsequently provided to AIHW NPESU for collation into a National 
Maternal Death Report Data Set and reviewed by the NMMAC. 
State and territory maternal mortality committees  
A confidential enquiry into the maternal deaths that occurred in 2008–2012 was undertaken 
by 7 STMMCs. The Northern Territory did not convene a committee during this time period. 
The confidential enquiry process seeks to identify and understand the individual 
circumstances surrounding each death with a view to improving future maternity care and 
maternal and perinatal outcomes. The committees operate under legal privilege and are 
provided with clinical information and the results of autopsy investigations where available. 
This enables the STMMC to agree on the causes of each death and assign the death to a 
maternal death category. The organisational and governance arrangements for STMMCs 
vary between jurisdictions (details of each jurisdiction’s maternal death data collection 
process is outlined in Appendix B).  
Reporting maternal deaths in 2008–2012 
The methodology used for this report is similar to previous reports. It includes 
epidemiological data on maternal deaths, the use of illustrative vignettes known as ‘case 
summaries’, clinical commentary and references to published guidelines for further 
education on specific clinical management where available and relevant.  
Maternal mortality in Australia has been reported nationally since 1964. Reports were 
triennial until the 2003–2005 triennium. Procedural difficulties led to a hiatus of 5 years, and 
a ‘catch-up’ process was commenced with a quinquennial 2006–2010 report (AIHW et al. 
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2014). This 2008–2012 rolling quinquennial report continues the ‘catch-up’ process. Caution 
is advised when comparing overlapping time periods.  
Minimal information related to the assessment of avoidable factors or preventability 
surrounding the deaths is included in this report. This was a decision of the NMMAC and 
was made due to the absence of a nationally consistent approach to assessment of 
preventability of deaths and the retrospective nature of the data collection. This information 
is not readily available or routinely collected in all jurisdictions.  
Data elements, such as maternal place of residence (and hence remoteness of residence), 
could not be presented with the necessary degree of accuracy for this report due to differing 
legislative frameworks governing the ability of STMMCs and health departments to share 
information regarding maternal deaths and their jurisdictional review. Formal mechanisms, 
including legislative changes, are needed for more effective data sharing between 
jurisdictional maternal mortality registration authorities and maternal mortality data 
collection and review committees. 
Case vignettes 
Case vignettes or summaries have been incorporated to provide opportunities for teaching 
and learning and practice improvement, as in previous reports. Care has been taken to 
remove or change information that could potentially identify any individual. A decision was 
made by the NMMAC to not identify Aboriginal and Torres Strait Islander status in the case 
summaries and to not have any case summaries in the chapter on Aboriginal and Torres 
Strait Islander women. Perturbation, where a number of cases may have been combined, was 
used in the case summaries to prevent identification.  
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3 Maternal deaths in Australia in 2008–
2012 
Information about the deaths of 135 women that occurred during pregnancy or up to 42 days 
postpartum in Australia for the period 2008–2012 was provided to the AIHW NPESU. 
Following review by jurisdictional and national committees, 105 (78.0%) were classified as 
being directly or indirectly related to pregnancy, 27 were classified as incidental to the 
pregnancy, and 3 were unclassified deaths.  
Figure 3.1 and Table 3.1 show the distribution of maternal deaths between 2008 and 2012. 
Forty-nine of the 135 deaths (36.3%) were directly related to obstetric complications of the 
pregnancy and occurred while the woman was pregnant or within 42 days of the termination 
of the pregnancy. Fifty-three deaths (39.3%) were classified as indirect maternal deaths and 
were considered to be due to non-pregnancy related conditions that were aggravated by the 
pregnancy or its management. Three maternal deaths (2.2%) were considered to be related to 
the pregnancy or its management, but could not be further classified as either direct or 
indirect.  
Twenty-seven of the remaining 30 deaths, or 20.0% of all reported maternal deaths, were 
considered to be incidental to the pregnancy or its management. Of the remaining 3 (2.2%) 
deaths, there was insufficient information to classify them and they were categorised as 
unclassified deaths of women during pregnancy and the puerperium. No further 
information is presented about unclassified deaths in this report. Incidental and unclassified 
deaths are not included in the calculation of MMRs.  
 
Figure 3.1: Maternal deaths by classification and incidental deaths, Australia, 2008–2012 
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3.1 Maternal mortality ratio 
There were 105 maternal deaths between 2008 and 2012. The maternal mortality ratio (MMR) 
is a proportion that uses the number of direct, indirect and maternal deaths not further 
classified in the numerator and the number of women who gave birth in Australia to babies 
of at least 400 grams birthweight or at least 20 weeks gestation as the denominator. It is 
calculated over a defined time period. The MMR for the period 2008–2012 is 7.1 per 100,000 
women who gave birth (Table 3.1). 
Table 3.1: Maternal mortality ratio, Australia, 2008–2012 
Year(a) 
Direct 
deaths 
Indirect 
deaths 
Maternal 
deaths not 
further 
classified 
Unclassified 
deaths(b) 
Incidental 
deaths(c) 
Total 
deaths 
Number of 
women who 
gave birth 
Maternal 
mortality 
ratio(d) 
2008 6 7 0 0 8 21 292,156 4.4 
2009 6 12 0 2 6 26 294,540 6.1 
2010 9 10 1 1 5 26 294,814 6.8 
2011 11 14 1 0 4 30 297,126 8.8 
2012 17 10 1 0 4 32 307,474 9.1 
Total 49 53 3 3 27 135 1,486,110 7.1 
(a) 2008–2012 is a 5-year period; 3-year reporting periods were used up to the end of the 2003–2005 triennium.  
(b) Insufficient information was available to classify 3 deaths; these deaths are not included in the MMR calculations. 
(c) These deaths are not included in the MMR calculations.  
(d) Per 100,000 women who gave birth. Includes direct deaths, indirect deaths and deaths not further classified. 
The MMR for 2008–2012 is similar to the most recently reported MMR for the period  
2006–2010 (6.8 per 100,000 women who gave birth) and the 2003–2005 triennium (8.4 per 
100,000 women who gave birth), and lower than the MMR of 11.1 per 100,000 women who 
gave birth reported for the 2000–2002 triennium.  
Triennial maternal mortality ratio  
For ease of international comparison, triennial historical comparisons are presented in Figure 
3.2 and Table 3.2 from 1973 to 2011. Prior to the 1973–1975 triennium, definitional differences 
were such that only the direct MMR can be compared. There has been a statistically 
significant (p < 0.05) decline in total MMR between 1973–1975 and 2009–2011, and the 
fluctuations in the MMR over the period reflect the variability in rare death reporting. 
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Note: 1964–1966, 1967–1969 and 1970–1972 triennia are not included in this figure due to definitional differences in use for those periods. 
Figure 3.2: Maternal mortality ratios by triennium, Australia, 1973–2011 
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Table 3.2: Maternal mortality ratios by triennium, Australia, 1973–2011 
Years Direct 
deaths(a) 
Associated deaths Number of women 
who gave birth 
Direct maternal 
mortality ratio(b) 
Maternal 
mortality ratio(c) 
1964–1966 202 73 667,649 30.3 Not calculated 
1967–1969 166 71 713,064 23.3 Not calculated 
1970–1972 150 94 790,818 19.0 Not calculated 
  Indirect 
deaths 
Incidental 
deaths 
   
1973–1975 60 32 45 726,690 8.3 12.7 
1976–1978 52 35 19 678,098 7.7 12.8 
1979–1981 54 34 9 682,880 7.9 12.9 
1982–1984 42 25 27 713,985 5.9 9.4 
1985–1987 32 30 24 726,642 4.4 8.5 
1988–1990 37 33 26 754,468 4.9 9.3 
1991–1993 27 22 36 769,253 3.5 6.2 
1994–1996 46 20 34 767,448 6.0 8.6 
1997–1999 34 30 28 758,030 4.5 8.4 
2000–2002 32 52 3 753,901 4.2 11.1 
2003–2005 29 36 13 773,248 3.8 8.4 
2006–2008 24 35 15 859,088 2.8 6.9 
2009–2011 26 36 18(d) 886,480 2.9 7.2(e) 
(a) Data in this table from periods prior to 2006–2010 are based on historical reports and occasionally do not align with subsequent tables in 
the report for the 1973–75 and 1991–1993 triennia. 
(b) Maternal mortality ratio calculated from direct maternal deaths only, per 100,000 women who gave birth. 
(c) Maternal mortality ratio calculated from direct and indirect maternal deaths, per 100,000 women who gave birth. Due to definitional 
differences, this cannot be calculated for the 1964–1966, 1967–1969 and 1970–1972 triennia. Therefore, these triennia cannot be 
compared with those that follow. 
(d) Includes 3 unclassified deaths. 
(e) Includes 2 maternal deaths not further classified as either direct or indirect. 
Note: Table does not include 2012 data because triennium data are incomplete. 
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3.2 State and territory maternal mortality ratios 
The MMR varied by state and territory of death (Table 3.3), ranging from 3.3 deaths per 
100,000 women who gave birth in Tasmania to 25.8 deaths per 100,000 women who gave 
birth in the Northern Territory: the least populous jurisdiction in Australia. The variation 
between the states’ MMRs may reflect case identification within each jurisdiction, and the 
NMMAC believes that uniform mandatory reporting of all maternal deaths would be 
warranted. The small number of deaths indicates that caution should be used when 
interpreting the state and territory MMRs. 
Table 3.3: Maternal deaths by type of death, state and territory of usual residence, 2008–2012 
State and 
territory 
Number of 
women who 
gave birth 
Direct 
deaths(a) 
Indirect 
deaths(a) 
Direct and 
indirect 
deaths 
Maternal death 
not further 
classified 
Maternal 
mortality 
ratio(b) 
NSW and 
ACT(c) 507,519 14 15 29 1 5.9 
Vic 366,083 13 17 30 0 8.2 
Qld 306,129 13 12 25 1 8.5 
WA 156,979 0 5 5 1 3.8 
SA 99,319 5 1 6 0 6.0 
Tas 30,732 n.p. n.p. 1 0 3.3 
NT 19,349 n.p. n.p. 5 0 25.8 
Total(d) 1,486,110 49 53 102 3 7.1 
(a) Numbers may differ from those published in state and territory reports due to possible differences in the classification of maternal deaths by 
the NMMAC and the STMMCs. 
(b) Per 100,000 women who gave birth. 
(c) Includes 4 women whose state of usual residence was NSW and who died in another state or territory. 
(d) Includes 1 woman who died in Tasmania and whose state or territory of usual residence was unknown. 
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3.3 Causes of maternal deaths 
There were 105 maternal deaths, 49 of which were direct maternal deaths, 53 were indirect 
maternal deaths and 3 were maternal deaths that could not be classified due to insufficient 
information being available. Overall, the leading causes of maternal death in Australia in this 
5-year reporting period were cardiovascular disorders (16 deaths) and psychosocial deaths 
(16 deaths).  
Of the 49 direct maternal deaths, the leading causes were obstetric haemorrhage and 
thromboembolism, which together accounted for almost 43% of all direct maternal deaths 
(Figure 3.3, Table 3.4). Amniotic fluid embolism is less prominent in this period than in 
previous periods; it was still the most prominent cause of direct maternal death in New 
Zealand and the United Kingdom for the period 2008–2012 (Knight et al. 2014; PMMRC 
2014). Of concern is the continuing prominence of thromboembolic direct maternal deaths, 
despite the development of clear guidelines for thromboembolic prophylaxis in high-risk 
pregnancies (RCOG 2007, 2009a, 2009b). 
There were 53 indirect maternal deaths in Australia between 2008 and 2012, with 
cardiovascular deaths and deaths related to psychosocial morbidity remaining the leading 
causes of indirect maternal death (Figure 3.3, Table 3.4). The prominence of cardiovascular 
deaths was in line with the leading causes of indirect maternal death in New Zealand and 
the United Kingdom, which were pre-existing medical conditions and cardiac disease, 
respectively, and reflects the increasing age of mothers and increasing levels of obesity and 
other risk factors. Of note was the unusually high number of non-obstetric haemorrhage 
deaths from rupture of a splenic artery aneurysm, which is discussed in ‘Section 4.4 Non-
obstetric haemorrhage’ and 3 deaths related to the 2009 H1N1 influenza pandemic, which 
are discussed in ‘Section 4.5 Sepsis’ and were examined in detail in Maternal deaths in 
Australia 2006–2010 (AIHW et al. 2014). 
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Figure 3.3: Causes of maternal deaths, per cent, Australia, 2008–2012 
 
Table 3.4: Causes of maternal deaths, Australia, 2008–2012 
Cause of death Classification of deaths  Total 
Direct Indirect Maternal death not further classified 
 Number % 
Cardiovascular 1 15 0  16 15.2 
Psychosocial 1 14 1  16 15.2 
Obstetric haemorrhage 11 1 0  12 11.4 
Non-obstetric haemorrhage 3 9 0  12 11.4 
Sepsis (including H1N1 influenza) 4 7 1  12 11.4 
Thromboembolism 10 0 0  10 9.5 
Hypertensive disorders 9 0 0  9 8.6 
Early pregnancy death 5 1 0  6 5.7 
Amniotic fluid embolism 4 0 0  4 3.8 
Anaesthesia related death 1 1 0  2 1.9 
Other 0 5 0  5 4.8 
Unclassified 0 0 1  1 1.0 
Total 49 53 3  105 100.0 
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3.4 Demographic and clinical characteristics 
An understanding of the demographic and pregnancy characteristics of women who die is 
required to interpret the MMR accurately and plan services appropriately. Due to the 
distributed nature of data being contributed to the National Maternal Death Report Data Set, 
some demographic characteristics (e.g. postcode of normal residence, which would allow for 
a remoteness of residence statement) were not available for all women who died. 
Maternal age 
Table 3.5 shows maternal deaths between 2008 and 2012 by age group. The age of the women 
who died ranged from 17 to 50. The incidence of maternal death was higher at the extremes 
of reproductive age (Figure 3.4), with the lowest incidence of maternal death occurring 
between the ages of 25 and 34 (MMR 4.9 per 100,000 women who gave birth). Forty per cent 
(40%) of the maternal deaths occurred in the women who were aged 35 or over (MMR 12.4 
per 100,000 women who gave birth).  
Table 3.5: Maternal deaths by age group and percentage of women who 
gave birth by age group, Australia, 2008–2012  
Age group 
(years) 
Number of 
deaths(a) 
Percentage 
of deaths 
Number of 
women who 
gave birth 
Percentage of total 
number of women 
who gave birth MMR(b) 
<20 5 4.8 57,346 3.9 8.7 
20–24 14 13.3 208,903 14.1 6.7 
25–29 23 21.9 408,346 27.5 5.6 
30–34 20 19.0 471,743 31.7 4.2 
35–39 29 27.6 277,115 18.6 10.5 
≥40 13 12.4 60,785 4.1 21.4 
Total(c) 105 100.0 1,486,110 100.0 7.1 
(a) Direct, indirect and maternal deaths not further classified.  
(b) Per 100,000 women who gave birth. 
(c) Includes 1 woman of unknown age group. 
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Figure 3.4: Maternal mortality ratio by maternal age group, Australia, 2008–2012 
Age-standardised death rates for direct and indirect deaths between 2008 and 2012 are 
presented in tables 3.6 and 3.7. The numbers of deaths are small and reflect the variability of 
the rates over time by age groups. For direct maternal deaths, women aged 35 and older had 
the highest rates of maternal mortality in a number of the time periods, though this trend 
was not entirely uniform. For indirect deaths, however, there was no obvious trend.  
For direct deaths, the overall age-standardised rate for maternal mortality has trended 
downwards over the triennia. For indirect deaths, the overall age-standardised rate for 
maternal mortality has fluctuated over the triennia.  
Note that the age-standardised rates are expressed per 100,000 female population aged  
15–44, in contrast to the crude MMRs that are expressed per 100,000 women who gave birth. 
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Table 3.6: Age-specific and age-standardised maternal mortality rates: direct maternal deaths, 
Australia, 1973–2011 
Triennium 
Direct 
deaths(a) 
15–19 
years 
20–24 
years 
25–29 
years 
30–34 
years 
35–39 
years 
40–44 
years 
Age- 
standardised 
rate(b) 
1973–1975 66 0.25 1.10 1.14 0.42 0.57 1.00 0.74 
1976–1978 52 0.22 0.58 0.70 0.80 0.41 0.73 0.58 
1979–1981 54 0.17 0.80 0.60 0.74 0.39 0.54 0.54 
1982–1984 42 0.11 0.75 0.62 0.23 0.45 0.08 0.37 
1985–1987 32 0.20 0.25 0.40 0.52 0.27 0.00 0.28 
1988–1990 37 0.05 0.35 0.52 0.59 0.26 0.06 0.31 
1991–1993 27 0.00 0.09 0.44 0.28 0.34 0.16 0.22 
1994–1996 46 0.11 0.33 0.48 0.69 0.47 0.10 0.37 
1997–1999 34 0.00 0.20 0.27 0.37 0.58 0.14 0.27 
2000–2002 32 0.10 0.05 0.38 0.45 0.36 0.13(c) 0.25 
2003–2005 29 0.10 0.15 1.00 0.22 0.40 0.13 0.34 
2006–2008 24 0.10 0.14 0.19 0.18 0.34 0.13 0.18 
2009–2011 26 0.00 0.21 0.21 0.18 0.17 0.34 0.19 
(a) Data in this table from periods prior to 2006–2010 are based on historical reports and occasionally do not align. 
(b) Directly age-standardised to the Australian female population aged 15–44 at 30 June 2001. 
(c) Includes 1 woman aged over 44. 
Notes 
1. Rates expressed per 100,000 female population. 
2. Table does not include 2012 data because triennium data are incomplete. 
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Table 3.7: Age-specific and age-standardised maternal mortality rates: indirect maternal deaths, 
Australia, 1973–2011 
Triennium 
Indirect 
deaths(a) 
15–19 
years 
20–24 
years 
25–29 
years 
30–34 
years 
35–39 
years 
40–44 
years 
Age- 
standardised 
rate(b) 
1973–1975 30 0.06 0.42 0.57 0.31 0.53 0.19 0.35 
1976–1978 35 0.11 0.64 0.53 0.27 0.25 0.46 0.37 
1979–1981 34 0.17 0.39 0.65 0.36 0.30 0.09 0.33 
1982–1984 25 0.11 0.27 0.34 0.29 0.32 0.00 0.22 
1985–1987 30 0.30 0.20 0.75 0.16 0.11 0.00 0.25 
1988–1990 33 0.05 0.20 0.52 0.54 0.26 0.06 0.27 
1991–1993 21 0.15 0.09 0.24 0.32 0.15 0.05 0.17 
1994–1996 20 0.00 0.10 0.19 0.55 0.09 0.00 0.16 
1997–1999 28(c) 0.16 0.05 0.41 0.37 0.27 0.05 0.22 
2000–2002 52 0.15 0.26 0.75 0.90 0.22 0.13 0.41 
2003–2005 36 0.15 0.24 0.34 0.48 0.31 0.13 0.28 
2006–2008 35(d) 0.10 0.41 0.19 0.36 0.34 0.17 0.26 
2009–2011 36 0.09 0.26 0.21 0.53 0.37 0.09 0.26 
(a) Data in this table from periods prior to 2006–2010 are based on historical reports and occasionally do not align. 
(b) Directly age-standardised to the Australian female population aged 15–44 at 30 June 2001. 
(c) Data do not include 2 indirect deaths in the 1997–1999 triennium that were notified or amended after the 1997–1999 report was published. 
(d) Includes 1 woman aged over 44. 
Notes 
1. Rates expressed per 100,000 female population. 
2. Table does not include 2012 data because triennium data are incomplete. 
  
  Maternal deaths in Australia 2008–2012 19 
Table 3.8 shows the maternal deaths by age and parity. During the period 2008–2012, 62 of 
the women (59%) who died had between 1 and 3 previous pregnancies resulting in a birth. 
Eight (8%) of the women who died were of higher parity. 
Table 3.8: Maternal deaths by parity and age group, Australia, 2008–2012 
Age group 
(years) 
Parity (number)  
0 1 2 3 ≥4 Not stated Total 
<25 6 5 4 1 0 3 19 
25–29 6 8 4 3 2 0 23 
30–34 9 3 4 1 0 3 20 
35–39 4 7 9 5 2 2 29 
≥40 1 4 3 1 4 0 13 
Total(a) 27 27 24 11 8 8 105 
(a) Includes 1 woman of unknown age group. 
Demographics of the women who died 
Table 3.9 shows a number of demographic characteristics and the utilisation of antenatal care 
of the 105 women who died as a direct or indirect consequence of pregnancy. The table is 
stratified by the Indigenous status of the woman. Eight of the women were known to be 
Aboriginal and Torres Strait Islanders, 79 were known to be non-Indigenous and the 
Indigenous status of the woman was not known in 18 cases. Forty-two of the women (40%) 
who died were aged 35 or over. Sixteen of the women (16%) were overweight, with a BMI 
between 25 and 29.9, and 19 (19%) of the women were obese, with a BMI of 30.0 or more. 
Nineteen of the 61 women (31%) for whom smoking status was available, smoked during 
pregnancy, and 8 of the 32 women (25%) for whom alcohol status was known consumed 
alcohol during their pregnancy.  
Overall, the data available to NMMAC regarding the characteristics of women was poor  
(e.g. alcohol consumption information was not available for 77% of the women) and it is 
difficult to draw valid conclusions about these possible risk factors for maternal death.  
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Table 3.9: Characteristics of women who had direct and indirect maternal deaths, Australia,  
2008–2012 
  
Aboriginal and 
Torres Strait 
Islander women 
Non-Indigenous 
women 
Unknown 
status Total 
Maternal age         
Under 20 1 2 2 5 
20–24 4 9 1 14 
25–29 0 19 4 23 
30–34 0 19 1 20 
35–39 1 21 7 29 
40 or over 2 9 2 13 
Not stated 0 0 1 1 
Total 8 79 18 105 
Maternal BMI(a) at first antenatal visit         
Less than 18.5 0 1 0 1 
18.5–24.9 2 12 0 14 
25–29.9 1 12 3 16 
30 or more 2 14 3 19 
Not stated 3 40 12 55 
Total 8 79 18 105 
Smoking status during pregnancy         
Smoked 3 13 3 19 
Did not smoke 1 35 6 42 
Not stated  4 31 9 44 
Total 8 79 18 105 
Alcohol consumption status         
Alcohol consumed 2 4 2 8 
Alcohol not consumed 1 19 4 24 
Not stated  5 56 12 73 
Total 8 79 18 105 
Antenatal care         
0–2 antenatal visits 1 6 2 9 
3–5 antenatal visits 5 33 9 47 
Not stated 2 40 7 49 
Total 8 79 18 105 
(a) kg/m2. 
Note: Three maternal deaths were not able to be classified due to insufficient information being available. 
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Country of birth 
Table 3.10 shows the country of birth for the women who died. The majority (71.5%) were 
born in Australia. Nine of the women not born in Australia (whose country of birth was 
known) were born in New Zealand and 12 were born in the Asia-Pacific region.  
Table 3.10: Maternal deaths by country of birth, Australia, 2008–2012 
  Total number of 
women who gave birth 
Percentage of total 
number of women who 
gave birth 
Number of maternal 
deaths MMR 
Australia 1,062,483 71.5 64 6.0 
Other 415,274 27.9 26 6.3 
Unknown 8,353 0.6 15 . . 
Total 1,486,110 100.0 105 7.1 
Mode of birth 
Forty-three of the women (40.9%) who died had given birth by caesarean section, 20 (19.0%) 
had given birth by an unassisted normal vaginal birth and 8 (7.6%) had given birth by an 
assisted vaginal birth (forceps or vacuum assisted birth). The baby was unborn at the time of 
the woman’s death in 15 cases (14.3%) and the birth method was not stated for 17 women 
(16.2%)(Table 3.11). 
Table 3.11: Maternal deaths by type of death and mode of birth, Australia, 2008–2012 
  Type of death  
Mode of birth Direct Indirect 
Maternal death 
not further 
classified 
Total 
Unassisted normal vaginal birth 10 8 2 20 
Assisted vaginal birth(a) 4 4 0 8 
Caesarean section birth   22 21 0 43 
Baby not born 4 10 1 15 
Not stated 9 8 0 17 
Total 49 53(b) 3 105 
(a) Forceps or vacuum extraction-assisted vaginal births. 
(b) Total includes 2 fetal retrievals. 
Table 3.12 shows the urgency with which caesarean section was performed in the 43 women 
who died and who had a caesarean section birth. Eighteen of these caesarean sections (42%) 
were performed in response to an immediate threat to life of the mother or baby, while 15 
(35%) were performed with no immediate threat to the life or health of the mother or baby. 
Three caesarean sections (7%) were perimortem operations. There was limited information 
available regarding the indication for a number of these caesarean sections. 
  
 22 Maternal deaths in Australia 2008–2012 
Table 3.12: Maternal deaths by type of death and urgency of caesarean section, Australia, 2008–2012 
  Type of death 
Urgency of caesarean section Direct Indirect Total 
Immediate threat to life of mother or baby 10 8 18 
Maternal or fetal compromise with no immediate threat to life 6 4 10 
No maternal or fetal compromise but needs early delivery 0 1 1 
Delivery timed to suit woman or staff   3 1 4 
Peri- or postmortem 0 3 3 
Not stated 3 4 7 
Total 22 21 43 
Where women died 
Sixty-nine of the women died in a hospital. Thirty-eight of these women died a direct death 
and 31 women died an indirect death or a death not further classified (Table 3.13). Sixty-two 
per cent of these women died in an intensive care or operating theatre setting, with a further 
12% dying in an emergency department. There were no deaths in high-dependency or 
coronary care settings. 
Table 3.13: In-hospital maternal deaths by location and setting of death in hospital and type of 
death, Australia, 2008–2012 
  Number Direct (%) Indirect (%) Maternal death not further classified (%) 
Percentage of total 
hospital deaths (%) 
Maternity setting 3 33.3 33.3 33.3 4.3 
Intensive care unit 31 67.7 29.0 3.2 44.9 
Emergency department 8 37.5 62.5 0.0 11.6 
Mental health unit 2 0.0 100.0 0.0 2.9 
Operating theatre 12 75.0 25.0 0.0 17.4 
Other 4 25.0 75.0 0.0 5.8 
Unknown 9 33.3 66.7 0.0 13.0 
Total 69 55.1 42.0 2.9 100.0 
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Baby outcomes among maternal deaths 
Birth outcomes on 78 (74.3%) cases were available. Where data were available, 21% of babies 
were stillborn (Table 3.14). 
Table 3.14: Maternal deaths by baby outcome, Australia, 
2008–2012 
  Type of death  
  Direct Indirect 
Maternal death 
not further 
classified Total 
Live birth 31 30 1 62 
Stillbirth 6 9 1 16 
Not stated 12 14 1 27 
Total 49 53 3 105 
Incidence of autopsy 
Three-quarters of the women who died (76%) were the subjects of autopsy (Table 3.15). The 
NMMAC strongly suggests that all maternal deaths should be reported to the relevant 
Coroner and autopsy should be advocated where the cause of death is not clearly known. 
There were several deaths where a presumptive diagnosis was not confirmed by autopsy. 
Presumptive diagnoses of cause of death may not be correct (e.g. amniotic fluid embolism 
versus pulmonary thromboembolism). 
Table 3.15: Maternal deaths by performance of autopsy, Australia, 
2008–2012 
  Type of death  
  
Direct Indirect 
Maternal death 
not further 
classified Total 
Autopsy performed 36 41 3 80 
Autopsy not performed 13 8 0 21 
Not stated 0 4 0 4 
Total 49 53 3 105 
 
Good practice guidance 
• Autopsy should be advocated for all maternal deaths where the cause of death is not 
clearly known. 
Source: NMMAC. 
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3.5 Avoidability 
The presence or absence of avoidable factors was assessed in 80% of the 135 direct, indirect, 
unclassified and incidental maternal deaths (Table 3.16). This assessment was variably made 
by STMMC, root cause analyses (RCAs) and Coroners. Avoidability assessment was not 
available in 20% of deaths, due to legislation in some jurisdictions preventing provision of 
such information to the NMMAC and inactivity of individual STMMCs for some periods. 
Eighty-three per cent of the potentially avoidable factors were related to the provision of 
health care and 17% were related to the pregnant woman. 
Table 3.16: Assessment of avoidability of maternal deaths, Australia, 2008–2012 
Avoidability assessment Avoidability detail Total 
Potentially avoidable 
factors identified 
Factors related to health-care provision  
 Clinician operator error 3 
 Delay in accessing specialist assistance 1 
 Delayed diagnosis and transfer 7 
 Delayed emergency response by staff 4 
 Failure to follow recommended best practice 7 
 Failure to maintain adequate airway and ventilation post-operatively 1 
 Failure to recognise deteriorating patient condition 1 
 Inadequate communication between health services 4 
 Inadequate education and training of staff 1 
 Inadequate mental health care in pregnancy 1 
 Inadequate resuscitation 1 
 Inadequate screening for appropriate risk factors 2 
 Inadequate treatment and supervision of pre-eclampsia 1 
 Inappropriate care setting for level of clinical risk 1 
 Lack of an appropriate patient care plan 3(a) 
 Factors related to the pregnant woman  
 Driver error and failure to wear seatbelt 1 
 Failure to wear seatbelt 1 
 Excessive stimulant use by the woman 1 
 Inadequate maternal engagement with appropriate health care 4 
 Patient refusal of blood products 1(a) 
No avoidable factors 
identified 
– 63 
Avoidability not assessed – 27 
Total  136
(a) 
(a) Two factors present in 1 woman.  
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3.6 International comparisons 
In 2014, the World Health Organization (WHO) estimated that globally there were 289,000 
maternal deaths in 2013 (WHO 2014). The estimated global MMR in 2013 was 210 maternal 
deaths per 100,000 live births. The sub-Saharan Africa region alone accounted for 62% 
(179,000) of global deaths, followed by southern Asia at 24%. Almost one-third of all global 
maternal deaths occurred in India (50,000 deaths, 17%) and Nigeria (40,000 deaths, 14%). The 
rounded MMR of individual countries varied between 1,000 per 100,000 women who gave 
birth in Sierra Leone and 1 per 100,000 women who gave birth in Belarus and 2 per 100,000 
women who gave birth in Israel.  
Compared with the 5-year MMR of 7.1 deaths per 100,000 women who gave birth in 
Australia in 2008–2012, the 3-year rolling MMR reported from New Zealand in the years 
2010–2012 was 14.7 per 100,000 maternities with a decline from 18.2 per 100,000 maternities 
in 2006–2008 (PMMRC 2012). The United Kingdom reported an MMR of 11.4 per 100,000 
maternities in 2006–2008 (Cantwell et al. 2011) and 10.1 per 100,000 maternities in 2009–2011 
(Knight et al. 2014). The MMR in the United States of America was reported to be 16.0 per 
100,000 live births for the period 2006–2010 (Creanga et al. 2015), and has risen from 9.1 per 
100,000 in 1987–1990 (CDC 2014). In comparing the MMR from individual countries, it is 
important to be aware of differences in ascertainment and application of definitions. 
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4 Direct and indirect maternal deaths 
This chapter reviews direct and indirect maternal deaths by grouped causes of death, 
presented in order of frequency of the conditions that caused the death. For each of the 
grouped causes of death presented in this chapter, a standard set of information is provided. 
This includes an introduction to the topic, where available an introduction to morbidity data 
for the same condition, an overview of the information on the women who died along with 
incidence, demographic and morbidity information associated with the condition, and good 
practice guidance to highlight areas of clinical relevance that have been selected by relevant 
experts in the field of perinatal health.  
The small number of deaths in a number of the sections limits the interpretation of the data, 
and caution should be used when interpreting these results. 
4.1 Cardiovascular 
Cardiovascular disease-related maternal mortality 
Cardiovascular disease is the leading cause of death generally and the most common cause 
of death during pregnancy in industrialised countries. Pregnancy may unmask previously 
undiagnosed cardiovascular disease, due to the physiological changes that occur, including 
increased cardiac output related to increased blood volume and increased heart rate, and 
peripheral vasodilation with decreased systemic vascular resistance.  
Improved diagnosis and management of congenital heart disease has increased the number 
of women with pre-existing congenital heart disease surviving into adulthood and 
embarking on pregnancies (Bowater & Thorne 2010; Simpson 2012). Women are giving birth 
at older ages, with 22.4% of women who gave birth in 2012 being over the age of 35, and 
4.3% being over 40 (Hilder et al. 2014). Older mothers have higher rates of diabetes, 
hypertension, obesity, hyperlipidaemia and metabolic syndrome, concurrently adding to the 
population of pregnant women with acquired heart disease. 
Rheumatic heart disease (RHD) is a rare condition with high morbidity and mortality. The 
increased cardiac demands of pregnancy are often accompanied by the appearance of cardiac 
symptoms in those with RHD, even if they have been well and without symptoms before 
pregnancy. Although cases of RHD have mostly disappeared in Australia, Aboriginal and 
Torres Strait Islander women have among the highest documented rates of RHD in the 
world (AIHW 2004). The AMOSS (2013) commenced a national study of RHD in pregnancy 
in 2012. This study aims to provide an evidence base to improve clinical care and associated 
maternal and perinatal outcomes for women with RHD in pregnancy. 
Deaths from cardiac disease in 2008–2012 
There were 16 indirect maternal deaths from cardiac-related causes between 2008 and 2012, 
making cardiovascular disease the most common cause of maternal death for this period 
(along with psychosocial deaths). The maternal mortality ratio (MMR) for cardiac-related 
deaths for 2008–2012 was 1.1 per 100,000 women who gave births, compared with 1.0 in 
2006–2010 and 1.7 in 2003–2005 (Table 4.1).   
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The mortality rate for cardiovascular disease in Australia in 2008–2012 is of a similar order to 
the United Kingdom in 2010–2012 (MMR 2.25 cardiac deaths per 100,000 women who gave 
birth to 1 or more live or stillborn infants at 24 weeks or more gestation) (Knight et al. 2014). 
Table 4.1: Maternal deaths from cardiovascular disease, 
Australia, 2000–2012 
  Number Maternal mortality ratio(a) 
2000–2002 12 1.6 
2003–2005 13 1.7 
2006–2010(b) 15 1.0 
2008–2012(b)  16 1.1 
(a) Per 100,000 women who gave birth. 
(b) 2008–2012 and 2006–2010 are 5-year periods; previously 3-year reporting 
periods were used. 
Table 4.2 compares the causes of maternal deaths due to cardiovascular disease between 
2008 and 2012 with the previous 3 reporting periods.  
In 2008–2012, there were 4 deaths due to dissection of the aorta, 4 due to cardiomyopathy 
and 2 due to myocardial infarction. There were 2 deaths from other cardiac causes: 1 from 
acute bacterial endocarditis and 1 from Takayasu arteritis. There were 2 other deaths where 
the cause of death could not be determined, but a cardiac cause was likely.  
Table 4.2: Maternal deaths due to cardiovascular disease by cause, Australia, 2000–2012 
Cause of death  2000–2002 2003–2005 2006–2010(a) 2008–2012(a) 
Myocardial infarction 2 . . 2 2 
Atherosclerosis 1 . . 2 . . 
Congenital heart disease 3 3 3 . . 
Aortic dissection 2 3 3 4 
Cardiac failure 2 1 1 1 
Peripartum cardiomyopathy 1 1 . . 4 
Primary pulmonary hypertension 
diagnosed at autopsy . . 1 . . 
 
. . 
Hypertensive heart disease . . . . . . 1 
Takayasu arteritis . . . . 1 1 
Endocarditis   1 1 
Undetermined . . 1 2 2 
Total 11 10 15 16 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
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Table 4.3 shows the cause of death, age group, parity and timing of death for the 16 women 
who died from cardiovascular causes. The gestational timing of the deaths ranged across all 
3 trimesters of pregnancy, with more occurring in the third trimester and postpartum period. 
Eight of the 12 women were aged 30 or over. Of the 16 women who died, 1 died in early 
pregnancy, 2 died during the antepartum period, 3 died intrapartum and 10 died 
postpartum.  
Table 4.3: Maternal deaths due to cardiovascular disease, Australia, 2008–2012 
Cause of death 
Maternal 
age group Parity(a) BMI(b) Smoking status 
Indigenous 
status Timing of death 
Myocardial 
infarction 35–39 N 33.4 Did not smoke Non-Indigenous Postpartum 
Myocardial 
infarction ≥40 M 35.0 Did not smoke Non-Indigenous Antepartum 
Aortic dissection 25–29 N 26.5 Did not smoke Non-Indigenous Intrapartum 
Aortic dissection 30–34 N 26.5 Did not smoke Non-Indigenous Postpartum 
Aortic dissection 35–39 N 34.0 Not stated Non-Indigenous Postpartum 
Aortic dissection 30–34 N 17.0 Did not smoke Non-Indigenous Antepartum 
Cardiomyopathy 30–34 M 42.8 Not stated Non-Indigenous Postpartum 
Cardiomyopathy 20–24 M 32.9 Did not smoke Indigenous Postpartum 
Cardiomyopathy 30–34 M Not stated Not stated Non-Indigenous Postpartum 
Cardiomyopathy 
and congenital 
heart disease 25–29 M Not stated Not stated Non-Indigenous Postpartum 
Hypertensive and 
arrhythmic heart 
disease 35–39 N Not stated Did not smoke Non-Indigenous Postpartum 
Left ventricular 
failure of uncertain 
cause 30–34 N Not stated Did not smoke Non-Indigenous Intrapartum 
Infective 
endocarditis 20–24 N 19.7 Smoked Indigenous Early pregnancy 
Intracerebral 
haemorrhage 30–34 N 19.0 Did not smoke Non-Indigenous Postpartum 
Undetermined  35–39 M Not stated Not stated Non-Indigenous Intrapartum 
Undetermined 35–39 M Not stated Not stated Non-Indigenous Postpartum 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara. 
(b) BMI = body mass index. 
The NMMAC noted that early multidisciplinary care, including cardiology referral, is 
recommended for pregnant women with cardiac disease. Limited details on the pregnancy 
for the women discussed here were available and it is not known whether they were referred 
for specialist care early in pregnancy. 
For the 16 women who died of cardiovascular disease, comorbidities and lifestyle factors 
such as BMI, smoking status, hypertension and diabetes were not reported to the NPESU in a 
significant proportion of cases; therefore, such data are not able to be presented in this 
report.  
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Fifteen of the 16 women who died were referred to the Coroner and 14 had an autopsy. 
Autopsy allows clarification of the cause of death because numerous medical conditions may 
present with similar symptoms. There are also a number of cardiac diseases causing sudden 
cardiac death with a genetic basis that may have implications for family members.  
Good practice guidance 
• Autopsy should be advocated where the cause of a maternal death may be cardiac- 
related 
Source: NMMAC. 
Ischaemic heart disease 
There were 2 deaths in late pregnancy due to myocardial infarction. Both the women were 
aged over 35 and were obese. One had the known risk factors for cardiovascular disease of 
hypertension and diabetes mellitus.  
There was 1 death, which is reported in ‘Section 4.5 Sepsis’, where a known background of 
ischaemic heart disease contributed to the death of a woman with H1N1 influenza. 
Aortic dissection 
There were 4 deaths from aortic dissections in ruptured aortic aneurysms. One occurred in 
the second trimester of pregnancy, 1 early in the third trimester and the other 2 at term. The 
women who died were aged between 26 and 36.  
Case summary 
A primigravida at 37 weeks gestation had epigastric and chest discomfort, which she 
interpreted as gastro-oesophageal reflux and self-treated with antacids. Two days later 
she attended an emergency department with severe chest pain. During chest X-ray, she 
collapsed and was found to be pulseless. She did not survive despite cardiopulmonary 
resuscitation and perimortem caesarean section. Autopsy revealed a ruptured aortic 
dissection. There were no potentially avoidable factors found.  
Cardiomyopathy  
Four women died as a consequence of cardiomyopathy. All 4 women were non-Indigenous 
and aged under 35, and 2 were known to be significantly obese. Significant comorbidities 
were present in 3 of the women.   
One woman had corrected tetralogy of Fallot. A health practitioner who did not regularly 
participate in antenatal care saw her for pregnancy care and, despite episodes of shortness of 
breath, there was no plan to refer her to a maternity service for care or to a cardiologist until 
she entered the third trimester of pregnancy. 
Other deaths 
There was 1 death from infective endocarditis complicating ischaemic heart disease and 1 
from the sequelae of Takayasu arteritis. The 2 deaths from undetermined causes were 
sudden unexpected deaths. Both of these cases were reviewed by the Coroner and were 
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determined to be due to suspected ‘cardiac causes’, although the exact cause of death could 
not be determined.  
Preconception assessment and counselling 
Women with known heart disease should be properly assessed preconception. For those 
with congenital heart disease, discussions around pregnancy should be carried out at the 
onset of menarche and before pregnancy is planned. Counselling should be offered that 
includes discussion and advice on appropriate methods of contraception. It is unknown 
whether this occurred for the women whose deaths are presented in this chapter.  
Summary 
Cardiovascular disease represented 1 of the 2 largest causal groups of maternal deaths, along 
with psychosocial deaths, between 2008 and 2012 in Australia, and accounted for 15.2% of 
maternal deaths overall and 28.3% of indirect deaths. The risk of death due to cardiovascular 
disease is likely to rise with increases in cardiovascular risk factors including smoking, 
increasing maternal age, obesity, diabetes and hypertension. An increasing number of 
women with acquired cardiac disease, such as ischaemic heart disease, and with known 
congenital heart disease are embarking on pregnancies.  
Clinicians caring for pregnant women need to be aware of the increasing burden of 
cardiovascular disease in Australia. Consideration needs to be given to pre-existing or new-
onset heart disease in pregnant women who present with cardiovascular symptoms, and 
these patients should be referred for appropriate and timely cardiovascular investigation and 
management. This management may involve referral to a multidisciplinary tertiary hospital 
where there is expertise in the management of cardiac disease occurring in pregnancy 
(RANZCOG 2014a; RCOG 2011). 
Good practice guidance 
• Women with known cardiovascular disease should have access to pre-pregnancy 
counselling. This should ideally be offered at the onset of menarche and should 
include appropriate contraceptive advice. 
•  All women with high-risk pregnancies due to cardiovascular disease should be 
referred to appropriate multidisciplinary tertiary services that provide access to 
cardiac investigations and cardiologists and/or physicians with expertise in this area. 
•  Women with severe chest or abdominal pain must be investigated with appropriate 
thoracic or abdominal imaging. 
Source: NMMAC. 
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4.2 Psychosocial 
Severe psychosocial maternal mortality 
Up to 9.0% of antenatal women and up to 16.0% of postnatal women in Australia are affected 
by depression (Beyondblue 2008). The Clinical practice guidelines: Depression and related 
disorders—anxiety, bipolar disorder and puerperal psychosis—in the perinatal period (Beyondblue 
2011; Austin et al. 2011) aim to improve the prevention and early detection of antenatal and 
postpartum depression, and to provide better care, support and treatment for pregnant 
women, new mothers and their families. 
A significant proportion of maternal deaths occur among women with a previous psychiatric 
history (Austin et al. 2007). Evidence suggests that substance misuse and domestic violence 
often complicate deaths related to psychiatric illness, and in a minority can be the primary 
cause (Austin et al. 2007; Oates 2003). 
Classifying maternal deaths associated with psychosocial 
morbidity  
In Australia, each maternal death undergoes a thorough process of review and investigation 
in the form of a confidential death enquiry. As part of this process, there is the opportunity 
to reliably examine the circumstances surrounding each death on an individual basis and 
determine previous psychosocial morbidity.  
Since the 1997–1999 triennium, Maternal Deaths in Australia reports have classified deaths 
among women with a pre-existing psychiatric illness or psychiatric illness that developed 
during pregnancy and was not due to direct obstetric causes as indirect, and deaths deemed 
unrelated to the pregnancy due to ‘external causes’ as incidental. 
As discussed in Chapter 2, the NMMAC modified the classification methodologies for 
psychosocial deaths in late 2012. Maternal suicides in the specific setting of first-recognised 
onset of pregnancy-related psychiatric morbidity in the current pregnancy are to be classified 
as direct deaths. All other maternal suicides and psychosocial deaths due to causes such as 
substance abuse and homicide in a domestic violence setting would be classified as indirect 
deaths.  
Because this decision occurred at the end of the period covered by this report, most of the 
deaths were classified by the relevant STMMC using the previous classification 
methodologies.  
Deaths from psychosocial causes in 2008–2012 
For this report, the term ‘psychosocial causes’ describes deaths in which a psychiatric 
condition contributed to the cause of death, and encompasses the wider issues of domestic 
violence and substance misuse.  
Psychosocial morbidity, along with cardiovascular disease, was a leading cause of maternal 
death in Australia. There were 16 maternal deaths from causes related to psychosocial 
morbidity between 2008 and 2012. The MMR due to psychosocial morbidity has remained 
stable, ranging from 0.9 deaths per 100,000 women who gave birth in 2006–2010 to 1.2 deaths 
per 100,000 women who gave birth in 2003–2005 and in 2000–2002. In 2008–2012, the MMR 
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due to psychosocial morbidity was 1.1 deaths per 100,000 women who gave birth (Table 4.4). 
Australian maternal death reports prior to 2006–2010 used the term ‘psychiatric deaths’.  
Prior to 1997, deaths from psychiatric causes, apart from puerperal psychosis, were classified 
as incidental deaths, so comparisons with triennia prior to 1997 must be undertaken with 
caution. 
If the World Health Organization (WHO) recommendation that all maternal suicide deaths 
be classified as direct maternal deaths (Pattinson et al. 2009; WHO 2012) was used, 12 of the 
16 psychosocial deaths would be classified as direct deaths (rather than 1 death as classified 
by the relevant STMMC). This would have the effect of increasing the direct MMR (all 
causes) for this period from 3.3 per 100,000 women who gave birth to 4.0 per 100,000 women 
who gave birth, and decreasing the indirect MMR from 3.6 per 100,000 women who gave 
birth to 2.8 per 100,000 women who gave birth. The total MMR would remain unchanged at 
7.1 per 100,000 women who gave birth. 
Table 4.4: Maternal deaths related to psychosocial 
morbidity, Australia, 2000–2012 
Reporting period  Number Maternal mortality ratio(a) 
2000–2002 9 1.2 
2003–2005 9 1.2  
2006–2010(a) 13 0.9  
2008–2012(a) 16 1.1 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year 
reporting periods were used. 
Of the 16 women who died from causes related to psychosocial morbidity between 2008 and 
2012, 12 committed suicide, 2 were murdered, 1 was a known substance user who overdosed 
on illicit drugs with unknown intent and 1 had an adverse reaction to psychotropic 
medication (Table 4.5).  
Table 4.5: Maternal deaths due to psychosocial morbidity by cause, Australia, 2000–2012 
Cause of death 2000–2002 2003–2005 2006–2010(a) 2008–2012(a) 
Suicide 7 4 9 12 
Homicide . . 3(b) 2 2 
Overdose 1 2 2 1 
Other 1 . . . . 1 
Total 9 6 13 16 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
(b) Deaths due to homicide were previously reported in the ‘other category’ and not ‘psychiatric deaths’. 
Table 4.6 gives a summary of the women who died from causes associated with psychosocial 
morbidity in Australia between 2008 and 2010.  
Of the 12 women who committed suicide, 6 committed suicide by hanging and 4 took a drug 
overdose. The method of suicide for 2 women was not stipulated. The women who died 
were aged between 18 and 40. Three of the women died while they were pregnant and 6 
women died in the postnatal period. Two of the women who died in association with early 
pregnancy committed suicide after a termination of pregnancy; the indications for 
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termination of pregnancy are not known. Two of the 12 women who died by suicide were 
Aboriginal women. 
Two women were murdered; the circumstances of these deaths are not stated. One woman 
was a known intravenous substance abuser and she died of multiple drug toxicity. One 
woman was given Diazepam for anxiety in an emergency setting and collapsed shortly 
afterwards. 
Table 4.6: Maternal deaths due to psychosocial causes in Australia, 2008–2012  
Cause of 
death 
Timing of 
death 
Indigenous 
status 
Maternal 
age group 
Prior mental 
health illness 
Known mental 
health contact  
Receiving mental health 
treatment perinatally 
Suicide Postpartum Indigenous 20–24 Not stated No No 
Suicide Postpartum 
Non-
Indigenous 30–34 
Known but not 
specified Yes Yes 
Suicide Antepartum 
Non-
Indigenous 20–24 Depression No No 
Suicide Postpartum 
Non-
Indigenous 25–29 
Known but not 
specified Yes Yes 
Suicide 
Early 
pregnancy Not stated 30–34 Not stated No No 
Suicide 
Early 
pregnancy 
Non-
Indigenous 30–34 
Known but not 
specified No No 
Suicide Postpartum 
Non-
Indigenous 35–39 
Anxiety and 
depression No No 
Suicide 
Early 
pregnancy Not stated 20–24 Not stated No No 
Suicide 
Early 
pregnancy 
Non- 
Indigenous  <20 Not stated No No 
Suicide Antepartum Indigenous <20 
Anxiety and 
depression Yes Yes 
Suicide Postpartum 
Non-
Indigenous 25–29 Not stated Not stated Not stated 
Suicide Postpartum 
Non-
Indigenous 35–39 Not stated Yes Yes 
Adverse 
medication 
reaction  Postpartum 
Non- 
Indigenous  25–29 
Anxiety and 
depression Yes Yes 
Multiple 
drug toxicity Antepartum Not stated <20 Depression No No 
Homicide Postpartum 
Non- 
Indigenous  20–24 Not stated No No 
Homicide Postpartum Indigenous 35–39 Not stated Not stated Not stated 
Eight of the women who committed suicide were known to have a prior mental health 
illness. Austin et al. (2007) suggest ‘that such deaths may have been avoided if there had 
been adequate monitoring of the women’s mental health status’. Five of these 8 women had a 
known mental health contact and were receiving mental health treatment.  
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Case summary 
A multiparous woman was known to have mental health issues during the antenatal 
period and was under the care of a mental health liaison service. She took an overdose 
of her psychotropic medication 2 weeks postpartum. Review of this death considered 
that there was inadequate mental health care during the pregnancy and postpartum 
follow-up after discharge from the maternity unit was inadequate. 
 
Case summary 
A young woman sought a termination of pregnancy via a private service provider sited 
a long distance from her home. A counsellor confirmed that she was making a clear 
decision to terminate her pregnancy, and that the underlying reason for this request 
was that she did not wish for children at that time in her life. Termination of pregnancy 
was performed on the grounds of ‘psychosocial emotional wellbeing’. There was no 
agreed follow-up plan by any health-care provider. A relationship breakdown 
subsequently occurred and she committed suicide 3 weeks after the procedure. Review 
of this death concluded that there was inadequate attention paid to post-termination 
follow-up. 
Summary 
Psychosocial morbidity is a leading cause of maternal death in Australia. Except for maternal 
suicide following first recognised onset of pregnancy-related psychiatric morbidity (i.e. 
puerperal psychosis and postnatal depression), the NMMAC has classified maternal deaths 
due to psychosocial causes as indirect deaths. The high proportion of deaths occurring in 
women with a known psychiatric history highlights the importance of antenatal and 
postnatal mental health screening. The adoption of antenatal psychosocial screening and 
guidelines for the management of psychiatric illnesses in the perinatal period are timely 
initiatives in preventing maternal deaths related to psychosocial morbidity.  
Good practice guidance 
• The antenatal period presents an opportunity to assess and monitor women’s 
psychosocial wellbeing and provide access to appropriate mental health services. 
Source: NMMAC. 
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4.3 Obstetric haemorrhage 
Obstetric haemorrhage-related maternal mortality 
Recent Australian reports indicate that severe postpartum haemorrhage (PPH) and its 
associated morbidity are increasing in incidence (Roberts et al. 2009), with international data 
suggesting that increases in uterine atony are involved in many of these instances (Callaghan 
et al. 2008).  
The risk of peripartum hysterectomy associated with morbidly adherent placentation has 
also risen in recent decades, in association with the increasing caesarean section rate. The 
UKOSS study, undertaken between February 2005 and February 2006, estimated that the 
incidence of peripartum hysterectomy to control haemorrhage was 4.1 per 10,000 women 
who gave birth to 1 or more live or stillborn infants at 24 weeks gestation or above (95% CI 
3.6–4.5 per 10,000 women giving birth). Peripartum hysterectomy was strongly associated 
with previous caesarean section birth, and the risk rose with the increasing number of 
previous caesarean births, maternal age over 35 and parity greater than 3 (Knight et al. 2008). 
In 2011, there were 95,894 caesarean sections performed in Australia, or 32.4% of all births 
(Hilder et al. 2014), and the incidence of caesarean section birth has been increasing steadily 
for some years. 
An AMOSS study, described at <http://www.amoss.com.au/page.php?id=49>, has 
examined massive obstetric haemorrhage events and publication of the outcomes is awaited.  
Deaths from obstetric haemorrhage in 2008–2012 
Obstetric haemorrhage remains a major cause of maternal death in Australia and worldwide. 
It encompasses both antepartum and postpartum bleeding and can be defined as bleeding 
from the genital tract with an estimated blood loss of >500 mL, with blood loss of >1,000 mL 
or a blood loss that causes clinical signs of shock. Because obstetric blood loss is difficult to 
quantify, clinical signs of shock were recommended by RCOG as an addition to the 
volumetric definition (RCOG 2009b). Other non-obstetric causes of major bleeding (such as 
splenic artery aneurysm rupture) may also occur during pregnancy and the postpartum 
period, and these are reported in ‘Section 4.4 Non-obstetric haemorrhage’.  
There were 12 deaths due to obstetric haemorrhage between 2008 and 2012, giving an MMR 
of 0.8 per 100,000 women who gave birth (Table 4.7). Eleven (11) of these deaths were 
classified as direct maternal deaths and 1 as an indirect maternal death because it occurred 
following blunt trauma to the abdomen.  
Obstetric haemorrhage continues to be an important cause of maternal mortality, ranking in 
the top 4 causes of direct death in Australia since 1997 (AIHW et al. 2007). For this reporting 
period, it is the third most common cause of maternal death, behind cardiovascular and 
psychosocial deaths and the most common direct cause of maternal death. Table 4.7 shows 
the MMR for deaths due to obstetric haemorrhage for the last 4 reporting periods.  
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Table 4.7: Maternal deaths from obstetric 
haemorrhage, Australia, 2000–2012 
Reporting 
period  Number Maternal mortality ratio(a) 
2000–2002 9 1.2 
2003–2005 4 0.5 
2006–2010(b) 8 0.6 
2008–2012(b) 12 0.8 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year 
reporting periods were used. 
Five of the 12 deaths due to obstetric haemorrhage were related to the presence of 
pathological placentation (placenta accreta and/or percreta), and 5 were due to PPH  
(Table 4.8). One antepartum haemorrhage was related to blunt abdominal trauma.  
Table 4.8: Maternal deaths due to obstetric haemorrhage by cause, Australia, 
2006–2012 
Cause of death 2006–2010(a) 2008–2012(a) 
Postpartum haemorrhage 3 5 
Intrapartum haemorrhage 1 0 
Combined intrapartum and postpartum haemorrhage 1 1 
Placenta percreta/accreta 2 5 
Traumatic placental laceration and haemorrhage 1 1 
Total 8 12 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
The women who died of obstetric haemorrhage were aged from 23 to 50, with 5 of the twelve 
aged 35 or over. Two had spontaneous normal vaginal births, 7 gave birth by caesarean 
section and 1 had a forceps-assisted vaginal birth. Two of the women had not given birth at 
the time of their death. 
Table 4.9 shows details of the women who died from obstetric haemorrhage including age 
group, parity, BMI, smoking status, Indigenous status and timing of death in 2008–2012.  
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Table 4.9: Maternal deaths due to obstetric haemorrhage, Australia, 2008–2012 
Cause of death 
Maternal 
age group Parity(a) BMI(b) Smoking status 
Indigenous 
status 
Timing of 
death 
Placenta accreta 20–24 M 39.8 Did not smoke Non-Indigenous Postpartum 
Placenta praevia/percreta 35–39 GM 28.7 Smoked Not stated Postpartum 
Placenta accreta/percreta 20–24 M Not stated Did not smoke Non-Indigenous Antepartum 
Placenta accreta/percreta 35–39 M 21.5 Did not smoke Non-Indigenous Postpartum 
Placenta accreta/percreta 20–24 M 28.1 Did not smoke Non-Indigenous Postpartum 
Postpartum haemorrhage 30–34 M 21.5 Not stated Non-Indigenous Postpartum 
Postpartum haemorrhage 30–34 N Not stated Did not smoke Non-Indigenous Postpartum 
Postpartum haemorrhage 25–29 M Not stated Did not smoke Not stated Postpartum 
Postpartum haemorrhage 35–39 M 22.3 Did not smoke Non-Indigenous Postpartum 
Postpartum haemorrhage ≥40 M 27.8 Did not smoke Non-Indigenous Postpartum 
Uterine rupture ≥40 GM 28.6 Smoked Non-Indigenous Postpartum 
Blunt trauma to abdomen 25–29 M 32.3 Not stated Non-Indigenous Antepartum 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara; GM = grand multipara. 
(b) BMI = body mass index. 
Postpartum haemorrhage 
Four of the 5 women who died as a result of PPH were of parity greater than 2, while 1 had 
given birth to her first baby. In addition, the woman who had a uterine rupture in 
spontaneous labour died as a consequence of severe PPH. 
Case summary 
A 34-year-old woman who had previously given birth twice by caesarean section suffered 
a catastrophic postpartum haemorrhage of unknown cause in association with a repeat 
caesarean section, and died after a cardiac arrest in the course of management of her PPH. 
At a coronial inquest (DAGJ 2011), it was noted that prostaglandin F2 alpha (PGF2α) was 
administered to this woman in 2 intramyometrial doses of 1.5 mg very close to each other, 
rather than the usual recommended several small doses some minutes apart from each 
other with a maximum not to exceed 3 mg. Cardiac arrest occurred shortly afterwards. The 
Coroner highlighted the importance of taking care with administering PGF2α in the 
appropriate dilutions. Recommendations made by that Coroner include: 
• An agreed and documented protocol for the management of postpartum haemorrhage 
and other obstetric emergencies should be made available to maternity service staff. 
• All birth attendants should be trained in the management of postpartum haemorrhage.  
• A flow chart should be freely available in the operating theatre and labour ward, and 
clear dosage instructions should be available in the emergency box for the use of 
PGF2α, especially as this is a drug that is used infrequently and with which staff may 
not be completely familiar.  
• A laminated diagram showing how to insert a uterine compression suture should be 
available in the operating theatre. 
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Good practice guidance 
• All hospitals with maternity services should have clear guidance regarding the use of 
prostaglandin F2 alpha (PGF2α), which should be freely available in the operating 
theatre and birth suite. 
Sources: NMMAC; DAGJ 2011. 
 
Case summary 
A woman in her 20s, with a history of caesarean section in her 1 previous birth, 
laboured spontaneously in a low-risk care maternity setting. After an unassisted 
vaginal birth of a healthy baby, she had persistent excessive primary postpartum blood 
loss. After several hours of various attempts to stop her PPH, the woman remained 
hypotensive and developed acute circulatory collapse. She was transferred to a major 
maternity service with access to intensive care but died 2 days later with multi-organ 
failure. Review found that the assessment of blood loss and recognition of PPH and 
subsequent management were inadequate. Delay in the first blood transfusion and 
delay in escalation procedures in the first 4–6 hours were thought to be pivotal to this 
fatal outcome. 
For the most part, PPH is unpredictable and sudden, and when catastrophic may result in 
serious morbidity or death.  
A Cochrane review showed that active management of the third stage, when compared with 
physiological management, decreases the risk of blood transfusion (Begley et al. 2011). A 
further Cochrane review showed that ‘Prophylactic oxytocin at any dose used routinely after 
birth can reduce blood loss with fewer side effects than ergot alkaloids’ (Westhoff et al. 2013). 
Active management includes the administration of prophylactic oxytocics and controlled 
cord traction (RANZCOG 2014b). 
Good practice guidance 
• Active management of the third stage of labour (use of prophylactic oxytocics and 
controlled cord traction) decreases the risk of PPH and blood transfusion and should 
be recommended to all women. 
Sources: RANZCOG 2014b; RCOG 2009b. 
Placenta accreta 
Five of the women who died of obstetric haemorrhage had a morbidly adherent placenta as 
the underlying cause of their haemorrhage. All 5 women had had at least 1 previous 
caesarean section and all developed disseminated intravascular coagulopathy during the 
course of their terminal event.  
Additionally, a woman who had a caesarean hysterectomy for a known placenta percreta, 
and who had Factor V Leiden deficiency, subsequently died from pulmonary 
thromboembolism in association with a postpartum hernia repair procedure. 
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Case summary 
A multipara who had previously had 2 caesarean sections presented to hospital and 
collapsed after several hours of abdominal pain and sudden onset of shortness of 
breath. Prompt laparotomy revealed uterine rupture and evidence of placenta percreta 
and a hysterectomy was performed. She subsequently developed disseminated 
intravascular coagulopathy and signs of persistent intra-abdominal haemorrhage. She 
died shortly after a repeat laparotomy failed to find a controllable source of persistent 
intra-abdominal blood loss. There were no potentially avoidable factors found. Review 
noted that this cause of severe obstetric haemorrhage was becoming more frequent in 
association with the rising caesarean section rate in Australia. 
Morbid adherence of the placenta to the uterine wall is a potentially life-threatening 
condition, and may be suspected when there is a placenta praevia in a woman with a history 
of caesarean section or other uterine surgery. The incidence of placenta accreta has increased 
with the rising caesarean section rate and increasing maternal age (RANZCOG 2014a). 
Accurate diagnosis antenatally may allow for appropriate planning of delivery to minimise 
morbidity.  
The Royal Australian and New Zealand College of Obstetrics and Gynaecology (RANZCOG) 
has released the following statement on the management of placenta accreta (RANZCOG 
2014a).  
RANZCOG statement on the management of placenta accreta  
• Where there is suspected or known placenta accreta, delivery should occur in a place 
with the necessary medical facilities and expertise to manage these high-risk cases. It is 
important to be cognisant of the risk of placental growth to the serosa of the uterus, 
and into adjacent organs such as the bladder in extreme circumstances. 
• Antenatal attention to optimisation of haemoglobin and iron stores is important. 
• Such facilities would include access to ‘cellsaver’, an ability to cope with high-volume 
blood transfusion, availability of other blood products (e.g. platelets, clotting factors) 
and appropriate specialised expertise (e.g. neonatal, senior obstetric and anaesthetic, 
haematological and intensive care). A multidisciplinary approach is required, 
including possible prior consultation with other medical specialists such as urologists, 
gynaecological oncologists, vascular surgeons, intensivists and interventional 
radiologists. 
• As with all women at risk of major obstetric haemorrhage, those with suspected 
placenta accreta should be encouraged to remain close to the planned hospital of 
confinement for the duration of the third trimester of pregnancy. An emergency 
contingency plan is strongly recommended. 
• The timing of the caesarean section should consider the desirability of performing it as 
an elective rather than an emergency procedure. The caesarean section should 
therefore usually be undertaken at an earlier gestation than for uncomplicated elective 
caesarean births or uncomplicated placenta praevia. 
(continued) 
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RANZCOG statement on the management of placenta accreta (continued) 
Three surgical management choices may be considered according to available expertise, 
geographical and individual circumstances: 
1. Delivery of the baby and attempted delivery of the placenta. This is associated with a 
high likelihood of hysterectomy but not invariably so. If this option is chosen, the 
surgeon must be prepared to proceed promptly to hysterectomy if needed and the 
anaesthetist prepared for massive transfusion as bleeding may be considerable while 
the hysterectomy is being undertaken. 
2. Delivery of the baby via a uterine incision distant from the placenta, quick repair of the 
uterus and en bloc hysterectomy. 
3. Delivery of the baby via a uterine incision distant from the placenta, trimming of the 
cord close to insertion site, full repair of the uterus and conservative management. 
About two-thirds of women will avoid a hysterectomy; one-third will still require a 
hysterectomy because of uncontrollable bleeding, which may be delayed up to several 
weeks, and this approach also has a significant risk of infectious morbidity. In addition, 
uncertainty as to the time of onset of secondary bleeding can tax available resources. 
This has serious implications if the patient is returning to a remote area with little 
facility to cope with sudden severe haemorrhage. 
Source: RANZCOG 2014b. 
Summary 
Obstetric haemorrhage remains a key cause of maternal mortality and severe morbidity. 
Identification of placentas encroaching on the lower uterine segment, especially in women 
who previously gave birth by caesarean section, is critical. Maternity units should have  
well-rehearsed protocols for team management of catastrophic obstetric haemorrhage. 
Active management of the third stage of labour, when compared with physiological 
management, decreases the risk of PPH and blood transfusion.  
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4.4 Non-obstetric haemorrhage 
Deaths from non-obstetric haemorrhage in 2008–2012 
Non-obstetric haemorrhage is defined as haemorrhage occurring from sites other than the 
genital tract.  
There were 12 maternal deaths due to non-obstetric haemorrhage between 2008 and 2012, 
giving an MMR of 0.8 per 100,000 women who gave birth (Table 4.10). In previous reporting 
periods, there were 12 deaths due to non-genital tract haemorrhage between 2006 and 2010, 5 
deaths between 2003 and 2005 and 9 deaths between 2000 and 2002 (Table 4.10).  
Table 4.10: Maternal deaths from non-obstetric 
haemorrhage, Australia, 2000–2012 
Reporting 
period  Number Maternal mortality ratio(a) 
2000–2002 9 1.2 
2003–2005 5 0.6 
2006–2010(b) 12 0.8 
2008–2012(b) 12 0.8 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year 
reporting periods were used. 
There were 5 deaths from ruptured splenic artery aneurysm, 5 deaths from intracranial 
haemorrhage and 1 each from haemorrhage from a pulmonary arteriovenous malformation 
and a retroperitoneal haemorrhage secondary to anticoagulation (Table 4.11).  
Table 4.11: Maternal deaths due to non-obstetric haemorrhage by cause, Australia, 2006–2012 
Cause of death 2006–2010(a) 2008–2012(a) 
Ruptured splenic artery aneurysm 5 5 
Intracranial haemorrhage 7 5 
Haemorrhage from a pulmonary arteriovenous malformation – 1 
Retroperitoneal haemorrhage – 1 
Total 12 12 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
  
 42 Maternal deaths in Australia 2008–2012 
The age group, parity, BMI, smoking status, Indigenous status and timing of death of the 
12 women who died are shown in Table 4.12. The majority of these women were aged over 
30 (9 of 12) and 4 of the 6, where BMI was known, were overweight or obese. Parity ranged 
from 0 to 4, and the majority of the women were postpartum at the time of death.  
Table 4.12: Maternal deaths due to non-obstetric haemorrhage, Australia, 2008–2012 
Cause of death 
Maternal 
age group Parity(a) BMI(b) 
Smoking 
status 
Indigenous 
status 
Timing of 
death 
Ruptured splenic 
artery aneurysm  35–39 M 28.2 Smoked Non-Indigenous Antepartum 
Ruptured splenic 
artery aneurysm  ≥40 M 41.7 Did not smoke Non-Indigenous Postpartum 
Ruptured splenic 
artery aneurysm  30–34 N Not stated Did not smoke Non-Indigenous Postpartum 
Ruptured splenic 
artery aneurysm  25–29 M 32.4 Smoked Non-Indigenous Postpartum 
Ruptured splenic 
artery aneurysm 25–29 N 32.3 Did not smoke Non-Indigenous Postpartum 
Intracranial 
haemorrhage 30–34 M Not stated Not stated Non-Indigenous Antepartum 
Intracranial 
haemorrhage 35–39 M Not stated Did not smoke Non-Indigenous Postpartum 
Intracranial 
haemorrhage 30–34 M 19.9 Did not smoke Non-Indigenous Postpartum 
Intracranial 
haemorrhage 25–29 GM Not stated Smoked Non-Indigenous Postpartum 
Intracranial 
haemorrhage 30–34 M Not stated Not stated Non-Indigenous Postpartum 
Anticoagulation and 
retroperitoneal 
haemorrhage 35–39 M Not stated Not stated Not stated Postpartum 
Haemorrhage from 
pulmonary 
arteriovenous 
malformation 35–39 M 25.6 Did not smoke Not stated Antepartum 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara; GM = grand multipara. 
(b) BMI = body mass index. 
Ruptured splenic artery aneurysm 
Five women died as a result of rupture of a splenic artery aneurysm (Table 4.12). These 
women were aged between 25 and 42; 3 of 5 were parous women and 4 of the 5 were 
overweight or obese (BMI not stated for the fifth woman). One woman was an insulin-
treated gestational diabetic.  
Although possible delay in making the diagnosis was noted in 1 woman, there were no 
specific avoidable factors found. 
Splenic artery aneurysm rupture is a rare and life-threatening condition. The majority of 
cases are asymptomatic until rupture, with sudden onset of abdominal pain followed by 
circulatory collapse. Prodromal signs of rupture, such as intermittent epigastric pain, left-
side pain or chest pain radiating to the left arm do occur in some cases. Confusion in 
diagnosis with other common maternity emergencies such as placental abruption, uterine 
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rupture or amniotic fluid embolism, as well as other conditions such as pulmonary 
thromboembolism, cholecystitis, appendicitis or perforated peptic ulcer disease may occur. 
Good maternal fetal outcome can only be achieved by early diagnosis and prompt treatment. 
(Sadat et al. 2008; Selo-Ojeme & Welch 2003). 
Good practice guidance 
• Ruptured splenic artery aneurysm should be considered in the differential diagnosis of 
a pregnant woman with severe and unexplained abdominal pain, regardless of 
whether pain or shock is the most prominent feature at the time of evaluation. 
Sources: NMMAC; Sadat et al. 2008. 
 
Case summary 
A multipara who had developed gestational diabetes was admitted to the maternity 
service with upper abdominal pain in the middle of the third trimester. There was some 
upper abdominal tenderness and a differential diagnosis of cholecystitis or gastro-
oesophageal reflux was considered. She was given analgesia and an upper abdominal 
ultrasound was planned. Before that ultrasound examination appointment, she was 
found collapsed at home and was not able to be resuscitated. Autopsy revealed an 
upper abdominal collection of blood clot and a ruptured splenic artery aneurysm. There 
were no potentially avoidable factors found. 
Intracerebral haemorrhage 
Only 1 of the 5 acute intracranial haemorrhages was associated with a vascular 
malformation. Age at death ranged from 29 to 38 (Table 4.12) and parity ranged from 0 to 4. 
Four of the 5 women were postpartum when the haemorrhage occurred.  
None of the haemorrhages were associated with labour. One of the women had been 
anticoagulated as she was known to be heterozygous for Leiden Factor V and had had 
thromboembolism in a previous pregnancy; 1 had post-caesarean section hypertension; and 
1 haemorrhage was associated with significant substance abuse. Causative factors were not 
found in 2 cases. Delay in understanding the causation of symptoms was noted as potentially 
avoidable in 2 of the 5 cases. 
The women who died either collapsed suddenly at home or presented to hospital with a 
headache, and in some cases other neurological symptoms, and subsequently lost 
consciousness.  
The United Kingdom (UK) report, Saving lives, improving mothers’ care noted 26 deaths from 
intracerebral haemorrhage between 2009 and 2012. In most of these cases, there were no 
significant prodromal or warning symptoms. The UK report recommends that ‘Neurological 
examination including assessment for neck stiffness is mandatory in all new-onset headaches 
or headache with atypical features, particularly focal symptoms’ (Knight et al. 2014). 
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Good practice guidance 
• Neurological symptoms in pregnant women require an urgent neurological review 
and cerebral imaging if indicated.  
Sources: NMMAC; Knight et al. 2014. 
 
Case summary 
A multipara in her late 20s had an uneventful repeat elective caesarean section at 
38 weeks gestation at the end of an uneventful pregnancy. Two weeks after discharge 
from hospital, she complained of leg pain, but there were no abnormal clinical findings 
on medical review on that day. Two days later, her partner found her dead in bed. 
Autopsy revealed a subarachnoid haemorrhage secondary to a ruptured berry 
aneurysm. There were no potentially avoidable factors found. 
Summary 
Splenic artery aneurysm rupture most commonly occurs in multiparous women in the third 
trimester of pregnancy. It is a rare, but catastrophic, condition and should be included in the 
differential diagnosis for any pregnant women presenting with severe abdominal pain. 
Multidisciplinary care, specifically the involvement of a general surgeon, may improve 
chances of survival.  
Women presenting to hospital with potentially serious neurological conditions should be 
investigated as a matter of urgency and appropriate imaging undertaken. 
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4.5 Sepsis 
Sepsis-related maternal mortality 
There is currently limited available information on sepsis in pregnancy.  
A prospective UKOSS population-based case-control study on all severe infection in 
pregnancy from June 2011 to May 2012 has been undertaken to estimate the incidence of 
severe maternal sepsis in the UK (UKOSS 2014). The study aimed to investigate and quantify 
the associated risk factors, causative organisms, management and outcomes, and to explore 
whether any factors are associated with poor outcomes. The incidence of severe sepsis was 
4.7 per 10,000 maternities, and 5 women in this study group died (Acosta et al. 2014). The 
study report recommended that ‘Signs of severe sepsis in peripartum women, particularly 
with confirmed or suspected Group A streptococcal infection, should be regarded as an 
obstetric emergency’. 
Deaths from sepsis in 2008–2012 
Overall, there were 12 maternal deaths due to sepsis between 2008 and 2012, giving an MMR 
of 0.8 maternal deaths per 100,000 women who gave birth. This compares with an MMR of 
0.7 deaths due to sepsis per 100,000 women who gave birth between 2006 and 2010, and 0.6 
deaths due to sepsis per 100,000 women who gave birth between 2003 and 2005 (Table 4.13).  
Table 4.13: Maternal deaths from 
sepsis, Australia, 2000–2012 
Reporting period Number MMR(a) 
2000–2002 15 2.0 
2003–2005 5 0.6 
2006–2010(b) 10 0.7 
2008–2012(b) 12 0.8 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; 
previously 3-year reporting periods were used. 
For this report, deaths due to sepsis have been grouped into obstetric and non-obstetric 
infections. Differences in the circumstances of each case and classification method used 
across jurisdictions mean that the classification of direct versus indirect varies within these 
groups. Table 4.14 shows the maternal deaths from 2006 to 2012 due to sepsis and the cause 
of these deaths.  
There were 4 maternal deaths due to sepsis relating to pregnancy and its care. These women 
died from the following causes: endometritis, chorioamnionitis, postpartum puerperal sepsis 
and sepsis originating in a caesarean section wound. Three deaths from H1N1 influenza and 
1 death from influenza B were caused by respiratory infections that led to maternal deaths. 
Four disparate other septic deaths occurred due to: pneumococcal meningitis; an acute 
cholecystitis and toxic shock-like syndrome; necrotising fasciitis; and acute pyelonephritis. 
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Table 4.14: Maternal deaths from sepsis, Australia, 2006–2012 
Cause of death  2006–2010 2008–2012 
H1N1 influenza and its complications 3 3 
Influenza B – 1 
Endometritis/chorioamnionitis  2 2 
Puerperal sepsis 2 1 
Caesarean section wound sepsis – 1 
Acute cholecystitis and toxic shock-like syndrome 1 1 
Pneumococcal meningitis 1 1 
Lobar pneumonia 1 – 
Necrotising fasciitis of leg—group A streptococcus  – 1 
Acute pyelonephritis – 1 
Total 10 12 
Table 4.15 shows the causes of direct and indirect maternal death from sepsis, type and site 
of infection, and the age group of the women who died between 2008 and 2012. The age at 
death ranged from 20 to 42 and parity ranged from 0 to 4. Ten of the 12 women who died 
were postpartum at the time of their death. Five of the women were smokers, 3 women did 
not smoke, and the smoking status of the remaining women was unknown. BMI was known 
for 6 of the women: it was over 25 kg/m2 in all cases; the highest BMI was 53 kg/m2. 
Table 4.15: Deaths from sepsis, Australia, 2008–2012 
Cause of death 
Maternal 
age group Parity(a) BMI(b) Smoking status 
Indigenous 
status 
Timing of 
death 
H1N1 Influenza ≥40 M 36.8 Did not smoke Non-Indigenous Postpartum 
H1N1 Influenza 35–39 M Not stated Not stated Non-Indigenous Postpartum 
H1N1 Influenza 20–24 N Not stated Did not smoke Non-Indigenous Postpartum 
Influenza B <20 N 26.5 Not stated Non-Indigenous Antepartum 
Endometritis ≥40 GM 36.7 Not stated Indigenous Postpartum 
Chorioamnionitis 35–39 M Not stated Smoked Not stated Postpartum 
Puerperal sepsis Not stated N Not stated Not stated Not stated Postpartum 
Caesarean wound 
sepsis ≥40 GM Not stated Smoked Non-Indigenous Postpartum 
Cholecystitis 20–24 M 27.1 Smoked Indigenous Postpartum 
Pneumococcal 
meningitis 35–39 M Not stated Smoked Non-Indigenous Antepartum 
Necrotising fasciitis 20–24 M 28.4 Did not smoke Non-Indigenous Postpartum 
Acute pyelonephritis 25–29 GM 53.0 Smoked Non-Indigenous Postpartum 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara; GM = grand multipara. 
(b) BMI = body mass index. 
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Obstetric infections 
Four of the women who died between 2008 and 2012 died from obstetric-related infections. 
Three of these 4 deaths were classified as direct maternal deaths and the course of events 
described for these women showed a rapid deterioration from mild onset of symptoms to 
death within hours or days.  
Case summary 
A multipara with a history of several previous caesarean sections and of intravenous 
substance abuse miscarried a second trimester pregnancy at home after a period of days 
in which she felt unwell. On subsequent admission to a maternity service, she was 
found to be highly febrile. Broad spectrum antibiotic cover was commenced and 
manual removal of placental tissue was undertaken, but was incomplete. She was 
subsequently transferred to a tertiary hospital with signs of an acute abdomen, 
impending disseminated intravascular coagulopathy and multi-organ failure. Despite 
ultrasound guided removal of further retained placental tissue, she died of the effects of 
septicaemia. Culture of the placental tissue showed Escherichia coli and Staphylococcus 
aureus. Review suggested that delay in seeking care on the part of the woman was a 
potential avoidable factor. 
Non-obstetric infections 
Physiological and immune changes occur in pregnancy, making women more susceptible to 
infections (Logan & Price 2011). Additionally, pregnancy can lead to delay in investigation, 
diagnosis and treatment of systemic infections. For these reasons, deaths due to non-genital 
tract infection, such as meningitis, are considered related to pregnancy and classified as 
indirect maternal deaths.  
Eight women died as a result of non-obstetric related (non-genital tract sepsis) infections. 
Three deaths were from H1N1 influenza; 1 death from influenza B; 1 death was from 
pneumococcal meningitis; 1 death was from subdural empyema and purulent meningitis 
with group A beta haemolytic streptococcal sinusitis; 1 was from cholecystitis following 
complicated recovery from a caesarean section; and 1 was consequent on necrotising fasciitis 
of the leg.  
Deaths from influenza 
There were 3 reported deaths from H1N1 influenza during the 2009–2010 pandemic and they 
have been examined in detail in the Maternal deaths in Australia 2006–2010 report (AIHW et 
al. 2014). A further death occurred in 2011 due to influenza B. All 4 deaths were classified as 
indirect.  
A collaborative AMOSS and Australian and New Zealand Intensive Care Society (ANZICS) 
study identified 3 maternal deaths in Australia and 3 maternal deaths in New Zealand 
during the 2009 H1N1 pandemic (ANZIC Influenza Investigators & AMOSS 2010). This 
population-based cohort study demonstrated that pregnant women, particularly in the 
second half of pregnancy, were more likely than non-pregnant women to develop critical 
illness associated with the 2009 H1N1 influenza, and there were poorer outcomes, including 
the death of the mother or baby for such women. Outcomes from intensive care treatment in 
this pandemic were also reviewed in conjunction with the UKOSS (Knight et al. 2011). 
Immunisation programs for pregnant women in such circumstances were supported.  
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Group A beta haemolytic streptococcus 
There were 3 deaths identified as being caused by group A beta haemolytic streptococcal 
(GAS) infection, accounting for 25% of all maternal deaths due to sepsis between 2008 and 
2012. Similarly, GAS infection accounted for 25% of all maternal deaths due to sepsis 
between 2006 and 2010. GAS is a community-acquired bacterium and up to 30% of 
individuals are asymptomatic carriers of GAS, whether in the throat or on the surface of the 
skin (Nicoll et al. 2012). Clinical signs of systemic GAS infection and management of severe 
sepsis are described in the box below.  
Good practice guidance 
• Diarrhoea and/or vomiting in pregnant women may be serious signs of sepsis and an 
indication for commencing antibiotic therapy. 
• Early investigation of non-specific symptoms in pregnant women is necessary to 
exclude serious infection. 
• Where an autopsy is performed, blood cultures should be taken for all cases as soon as 
is possible. 
Sources: NMMAC; Knight et al. 2014. 
Summary 
Overall, there were 12 maternal deaths due to sepsis between 2008 and 2012, giving an MMR 
of 0.8 per 100,000 women who gave birth. GAS was the most common bacterial pathogen 
associated with mortality in both Australia and the UK. All of the women who died 
deteriorated rapidly from mild onset of symptoms to death with hours or days. Early 
investigation of non-specific symptoms in pregnant women is necessary to exclude serious 
infection. Influenza poses a particular risk for pregnant women and vaccination against 
influenza should be encouraged. 
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4.6 Thromboembolism 
Thromboembolism-related maternal mortality 
Venous thromboembolism is the obstruction of a blood vessel, usually a large vein, with 
thrombotic material carried in the blood from its site of origin to block another vessel 
(Medforth et al. 2011). The most common sites for such thrombotic material to lodge when 
thromboembolism complicates pregnancy are the pulmonary circulation (pulmonary 
embolism) and the cerebral veins (cerebral venous thrombosis). The most common sources of 
thrombotic material are deep vein thrombosis in the leg or in the pelvic veins. 
Until recently, there was no reliable information available in Australia on the number of 
women who experience antenatal pulmonary thromboembolism or their outcomes. The first 
national population-based AMOSS study of antenatal pulmonary embolism was undertaken 
in Australia and New Zealand for the period 2010–2012, and has recently completed the data 
collection. Preliminary results for 2010–2011 showed an incidence of 1.2 cases per 10,000 
women giving birth to a baby of at least 20 weeks gestation or at least 400 grams birthweight 
(PMMRC 2013). There were no maternal deaths from the 104 antenatal pulmonary embolism 
cases in the AMOSS study.  
The 2009–2012 UK maternal mortality study (Knight et al. 2014) reported 26 direct maternal 
deaths due to thromboembolism with a maternal mortality rate of 1.08 per 100,000 
maternities. Though there was little comment in the 2009–2012 report, the previous UK 
report (Cantwell et al. 2011) noted that the incidence of major thromboembolism in the UK 
had decreased, and opined that this was related to the introduction of effective 
thromboembolic prophylaxis programs (RCOG 2007, 2009a). Identifiable risk factors for 
thromboembolic disease were noted in 70% of the women who died; the main risk factors 
identified were multiparity, obesity, older age, smoking and operative delivery. 
There is no published information on thromboprophylaxis use in pregnancy across 
maternity units in Australia. These data are collected in some states as a requirement for 
hospital accreditation, but are not available on a national basis.  
Deaths from thromboembolism in 2008–2012 
There were 10 maternal deaths due to thromboembolism between 2008 and 2012. The MMR 
for thromboembolism for 2008–2012 is 0.7 per 100,000 women who gave birth, which is 
slightly higher than the rate for 2006–2010 and 2003–2005 (Table 4.16). All of the women died 
from pulmonary thromboembolism and their deaths were all classified as direct deaths.  
Table 4.16: Maternal deaths from 
thromboembolism, Australia, 2000–2012 
Reporting period Number MMR(a) 
2000–2002 3 0.4  
2003–2005 5 0.6  
2006–2010(b) 9 0.6 
2008–2012(b) 10 0.7 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; 
previously 3-year reporting periods were used. 
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Table 4.17 is a summary of all maternal deaths, in which thromboembolism was a principal 
or contributory cause, that have been documented in Australia since 2000. 
Thromboembolism is still a leading cause of direct maternal death in Australia, ranging from 
18% of deaths in 1967–1969 to 5.6% in 2003–2005. When reviewed in conjunction with the UK 
research, the downward trend in the number of maternal deaths from thromboembolism is 
likely to reflect improved identification and management of at-risk women during the 
antenatal period.  
Table 4.17: Maternal deaths from thromboembolism, Australia, 2000–2012 
Reporting 
period 
Maternal deaths with thromboembolism as a principal or contributory 
cause 
Total 
number 
of deaths 
Thrombo- 
embolism 
deaths as a 
percentage 
of total 
During 
pregnancy 
After 
miscarriage 
or TOP(a) 
After 
ectopic 
pregnancy 
After 
vaginal 
birth 
After 
caesarean 
section Total  
2000–2002 2 0 0 2 2 6 84 7.1 
2003–2005(b) n.a. n.a. n.a. n.a. n.a. 5 90 5.6 
2006–2010(c) 2 0 0 3 4 9 99 9.0 
2008–2012(c) 3 2 0 2 3 10 105 9.5 
(a) TOP = termination of pregnancy. 
(b) The total number of deaths includes 5 deaths where the timing of death was unknown. 
(c) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
Table 4.18 is a summary of the timing of deaths from thromboembolism in relation to 
pregnancy and some demographic characteristics of these women. The women who died 
due to thromboembolism between 2008 and 2012 were aged between 26 and 42, with the 
majority being in their 20s. Parity ranged from 0 to 4, with 8 of the 10 women being parous. 
BMI was only stated for 3 of the women, and was in the significantly obese range for 2 of 
those 3.  
Four of the deaths occurred in early pregnancy, 1 in late pregnancy and 5 in the postpartum 
period. The early pregnancy deaths occurred: in a woman with a twin pregnancy at 11 weeks 
gestation; in a woman with benign intracranial hypertension and a benign pituitary tumour 
at 9 weeks gestation; in a woman with an in vitro fertilisation (IVF) pregnancy at 5 weeks 
gestation; and in a woman after a complete miscarriage at 6 weeks gestation. The death in 
later pregnancy occurred at 37 weeks gestation with no known risk factors for 
thromboembolism.  
Three of the postnatal deaths due to thromboembolism occurred after caesarean section. One 
women had a lethal pulmonary embolus 2 weeks post-caesarean section, despite being 
treated with a prophylactic anticoagulant regimen. A second woman, who was known to be 
heterozygous for Factor V Leiden deficiency and who had a caesarean hysterectomy for 
placenta percreta, had a pulmonary embolus after her prophylactic anticoagulant regimen 
was ceased. A third woman, who had an emergency caesarean section in the presence of 
HELLP (haemolysis, elevated liver enzymes, low platelet count) syndrome, with a further 
laparotomy for a subcapsular liver rupture, died at home 34 days postpartum. The 
remaining 2 women who died postnatally had their pulmonary embolus at 13 and 16 days 
postpartum; no risk factors for thromboembolism were identified in either woman. 
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Table 4.18: Deaths from thromboembolism, Australia, 2008–2012 
Cause of death 
Maternal 
age group Parity(a) BMI(b) Smoking status 
Indigenous 
status 
Timing of 
death 
Pulmonary 
embolism 25–29 M Not stated Smoked Non-Indigenous Postpartum 
Pulmonary 
embolism ≥40 N Not stated Not stated Not stated 
Early 
pregnancy 
Pulmonary 
embolism 35–39 GM 42.2 Smoked Not stated Postpartum 
Pulmonary 
embolism 25–29 M 19.9 Did not smoke Non-Indigenous Postpartum 
Pulmonary 
embolism ≥40 M Not stated Did not smoke Non-Indigenous Antepartum 
Pulmonary 
embolism 25–29 N Not stated Not stated Not stated 
Early 
pregnancy 
Pulmonary 
embolism 35–39 M 35.3 Did not smoke Not stated 
Early 
pregnancy 
Pulmonary 
embolism 25–29 M Not stated Not stated Non-Indigenous Postpartum 
Pulmonary 
embolism 25–29 M Not stated Did not smoke Non-Indigenous Postpartum 
Pulmonary 
embolism 25–29 M Not stated Not stated Non-Indigenous 
Early 
pregnancy 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara; GM = grand multipara. 
(b) BMI = body mass index. 
Data on contributing factors were poorly reported. The data collected for these women were 
of variable quality and adequate details of death were only provided for 4 of the 10 women 
described here. For the other 6 women, details of the use of thromboprophylaxis were 
unavailable. In most cases, it is not known whether they experienced respiratory symptoms 
prior to the morbid event.  
Case summary 
A multipara in her early 30s had a caesarean section at 33 weeks gestation in response 
to a major antepartum haemorrhage in association with a known placenta accreta. An 
intra-operative decision was made to extend the procedure to a caesarean hysterectomy 
to control haemorrhage. She was known to be a heterozygous carrier of the Leiden V 
mutation and had prophylactic heparin regimen until fully mobile 12 days post-
operatively. Eight days after cessation of the heparin, she collapsed and was not able to 
be resuscitated. A large saddle pulmonary embolus was found at autopsy. Review 
suggested that an anticoagulation regimen should have been continued for 6 weeks. 
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Autopsy 
Of the 10 women who died of thromboembolism, there were 8 autopsies. In the cases of 
sudden death, all of these autopsies resulted in the cause of death being identified. In the 2 
other cases, the cause of death was diagnosed by imaging prior to death. In any case where 
the cause of death is not clearly known, it is necessary to proceed to autopsy to establish the 
cause of death.  
The NMMAC firmly recommends autopsy in all cases of apparently embolic death and/or 
sudden unexpected death in association with pregnancy, because differentiation between 
pulmonary thromboembolism, amniotic fluid embolism and sudden death of cardiac origin 
is not always accurate. 
Good practice guidance 
• Where the cause of death is not clearly known, autopsy should be advocated to 
establish the cause of death. 
Source: NMMAC. 
Risk assessment and prevention 
In light of the Royal College of Obstetricians and Gynaecologists (RCOG) guidelines 
regarding risk and management of thromboembolism (RCOG 2007, 2009a, 2009b), all women 
should undergo a documented assessment of risk factors for thromboembolism in early 
pregnancy or before pregnancy. Women are at risk of venous thromboembolism (VTE) 
throughout pregnancy and into the postpartum period, and this assessment should be 
repeated if the woman is admitted to hospital for any reason or develops other inter-current 
problems. 
More than 2 in every 1,000 women giving birth in Australia are extremely morbidly obese 
(AIHW et al. 2007). Obesity remains a significant risk factor for VTE in pregnancy. Maternity 
service providers should ensure they have current guidelines/protocols on 
thromboprophylaxis in pregnancy including weight-specific advice on thromboprophylaxis 
(McLintock et al. 2012). The box below describes risk factors for thromboembolism in 
pregnancy. 
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Risk factors for venous thromboembolism in pregnancy 
Pre-existing 
• Previous venous thromboembolism 
• Thrombophilia 
• Heritable 
• Antithrombin deficiency 
• Protein C deficiency 
• Protein S deficiency 
• Factor V Leiden 
• Prothrombin gene G20210A 
• Acquired (antiphospholipid syndrome): 
• Persistent lupus anticoagulant 
• Persistent moderate/high-titre anticardiolipin antibodies or β2 glycoprotein 1 
antibodies 
• Medical comorbidities (e.g. heart or lung disease, systemic lupus erythematosus, 
cancer, inflammatory conditions (inflammatory bowel disease or inflammatory 
polyarthropathy), nephrotic syndrome (proteinuria > 3 g/day), sickle cell disease, 
intravenous drug user 
• Age >35 
• Obesity (BMI >30 kg/m2) either pre-pregnancy or in early pregnancy 
• Parity ≥3 
• Smoking 
• Gross varicose veins (symptomatic or above knee or with associated phlebitis, 
oedema/skin changes) 
• Paraplegia 
Obstetric 
• Multiple pregnancy 
• Assisted reproductive therapy 
• Pre-eclampsia  
• Caesarean section 
• PPH (>1 L) requiring transfusion  
• Prolonged labour 
• Mid-cavity rotational operative delivery 
(continued) 
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Risk factors for venous thromboembolism in pregnancy (continued) 
New-onset/transient 
• Surgical procedures in pregnancy or puerperium (e.g. evacuation of products of 
conception, appendectomy, postpartum sterilisation) 
• Potentially reversible conditions (e.g. hyperemesis gravidarum, dehydration) 
• Ovarian hyperstimulation syndrome 
• Systemic infection requiring antibiotics or admission to hospital (e.g. pneumonia, 
pyelonephritis, postpartum wound infection) 
• Long distance travel (>4 hours) 
BMI = body mass index; PPH = postpartum haemorrhage 
Note: Systemic lupus erythematosus may develop at later stages in gestation than the initial risk assessment, or may 
resolve; therefore, continuing individual risk assessment is important. 
Source: RCOG 2009a. 
 
Good practice guidance 
• All women should undergo a documented assessment of risk factors for VTE in early 
pregnancy or before pregnancy. This assessment should be repeated if the woman is 
admitted to hospital for any reason or develops other inter-current problems 
(McLintock et al. 2012; RCOG 2009b). 
• Institutions should have guidelines on the management of obesity in pregnancy and 
women requiring thromboprophylaxis should be placed on doses appropriate to their 
weight. 
Source: NMMAC. 
Summary 
Thromboembolism still remains a leading cause of maternal death in Australia. Several of the 
women who died had known risk factors, and in some cases these were multiple risk factors. 
However, this information was not available in all cases.  
Women are at risk of thromboembolism throughout pregnancy and into the postpartum 
period. All women should undergo a documented assessment of risk factors for 
thromboembolism in early pregnancy or before pregnancy. Institutions should ensure they 
have current guidelines/protocols on thromboprophylaxis in pregnancy and ensure that 
clinicians looking after pregnant women are aware of these guidelines and undertake risk 
assessments, because this has been shown to save mothers’ lives (McLintock et al. 2012; 
RCOG 2009b).  
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4.7 Hypertensive disorders 
Hypertensive disorder-related maternal mortality 
Hypertensive disorders in pregnancy are among the most common pregnancy complications 
and have been a leading cause of maternal death around the world for many years. The 
Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) defines 
hypertension in pregnancy as systolic blood pressure greater than or equal to 140 mmHg 
and/or diastolic blood pressure greater than or equal to 90 mmHg (Lowe et al. 2015). Severe 
hypertension requiring urgent treatment is defined as a systolic blood pressure greater than 
or equal to 170 mmHg with or without diastolic blood pressure greater than or equal to 
110 mmHg.  
Hypertension in pregnancy may be due to a number of conditions, with pre-eclampsia and 
eclampsia being the most common causes. Pre-eclampsia is a multi-system disorder unique 
to human pregnancy characterised by hypertension and multi-system involvement of renal, 
haematological, hepatic and neurological systems, and the fetus. Early onset pre-eclampsia 
(late second trimester and early third trimester) requires multidisciplinary care in a major 
maternity service with associated maternal fetal and neonatal intensive care specialists and 
services available. Continued careful postnatal observation of previously diagnosed pre-
eclampsia is necessary because the disease does not necessarily resolve after birth and many 
complications can occur at this time. 
Good practice guidance 
• The significance of hypertension in pregnancy should not be underestimated, and any 
woman who presents with signs or symptoms that are possibly due to pre-eclampsia 
should undergo a full clinical and laboratory assessment and early referral to a 
consultant obstetrician at a hospital with a service capability level for managing high-
risk pregnancies. 
• The management of women with pre-eclampsia between gestational ages of 24 and 
32 weeks should be undertaken in consultation with a tertiary institution. Prior to the 
birth of the baby, all efforts should be used to safely transfer a woman with pre-
eclampsia at such gestations to a facility with appropriate neonatal and maternal care 
capabilities. 
• Regular blood pressure monitoring should be undertaken at all antenatal visits past 
20 weeks gestation. The NMMAC recommends that urine testing be undertaken at all 
antenatal visits past 20 weeks gestation; at a minimum, urine testing be undertaken at 
all antenatal visits past 20 weeks gestation in women who are at particular risk of pre-
eclampsia and in all women where a raised blood pressure is found. 
Source: NMMAC. 
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Deaths from hypertensive disorders of pregnancy in 2008–2012  
There were 9 maternal deaths related to hypertensive disorders of pregnancy between 2008 
and 2012 (Table 4.19). All of these deaths were due to pre-eclampsia and its complications, 
and all deaths were classified as direct. The MMR during 2008–2012 for hypertensive 
disorders of pregnancy was 0.6 per 100,000 women who gave birth compared with 0.4 per 
100,000 women who gave birth in 2006–2010, and 0.8 per 100,000 women who gave birth in 
2003–2005.  
Table 4.19: Maternal deaths from 
hypertensive disorders, Australia, 
2000–2012 
Reporting period Number MMR(a) 
2000–2002 5 0.7  
2003–2005 6 0.8  
2006–2010(b) 6 0.4 
2008–2012(b) 9 0.6 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; 
previously 3-year reporting periods were used. 
Table 4.20 details deaths from hypertensive disorders of pregnancy by cause in Australia 
from 2000 to 2012. All 9 maternal deaths related to hypertensive disorders of pregnancy 
between 2008 and 2012 were due to sequelae of pre-eclampsia. Intracranial haemorrhage was 
the most commonly reported cause of death (7 women in total), although the majority 
suffered multiple complications and organ failure. One woman died as a result of a hepatic 
rupture and another woman died from hypoxic ischaemic encephalopathy.  
Good practice guidance 
• The major cause of death in women with hypertension in pregnancy is intracranial 
haemorrhage. Systolic blood pressure of 170 mmHg or above, or diastolic blood 
pressure of 110 mmHg or above, is a medical emergency and requires urgent in-patient 
assessment and management in a specialist maternity service. 
Source: NMMAC. 
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Table 4.20: Maternal deaths from hypertensive disorders, Australia, 2000–2012 
Cause of death 2000–2002 2003–2005 2006–2010(a) 2008–2012(a) 
Hypertension/pre-
eclampsia 3 – – – 
Intracranial 
haemorrhage  – 4 4 7 
Eclampsia 1 – 1 – 
Hepatic rupture – – 1 1 
Hypoxic ischaemic 
encephalopathy – – – 1 
Other 1 1 – – 
Total 5 5 6 9 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
The women who died were aged between 25 and 41 (Table 4.21). Parity ranged from 0 to 2. 
All of the women who died were at greater than 37 weeks gestation. It is disappointing that 
BMI information was not available for 7 of the 9 women.  
All 9 women had given birth prior to their death: 6 by caesarean section, 2 by vaginal birth 
after induced labour and 1 by vaginal birth after spontaneous labour.  
Table 4.21: Deaths from hypertensive disorders, Australia, 2008–2012 
Cause of death 
Maternal 
age group Parity(a) BMI(b) 
Smoking 
status 
Indigenous 
status 
Timing of 
death 
Intracranial 
haemorrhage 35–39 M Not stated Not stated Non-Indigenous Postpartum 
Intracranial 
haemorrhage ≥40 M Not stated Not stated Non-Indigenous Postpartum 
Intracranial 
haemorrhage ≥40 M Not stated Not stated Non-Indigenous Postpartum 
Intracranial 
haemorrhage 30–34 M Not stated Did not smoke Non-Indigenous Postpartum 
Intracranial 
haemorrhage 35–39 M Not stated Not stated Non-Indigenous Postpartum 
Intracranial 
haemorrhage 25–29 N Not stated Did not smoke Not stated Postpartum 
Intracranial 
haemorrhage 35–39 M Not stated Not stated Non-Indigenous Postpartum 
Hypoxic ischaemic 
encephalopathy 25–29 M 25.8 Not stated Non-Indigenous Postpartum 
Hepatic rupture 30–34 N 27.8 Did not smoke Non-Indigenous Postpartum 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara. 
(b) BMI = body mass index. 
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Pre-eclampsia 
All of the women who died developed multiple complications of pre-eclampsia and 
eclampsia, such as hepatic rupture, adult respiratory distress syndrome and disseminated 
intravascular coagulation, and all were admitted to an intensive care unit prior to their 
deaths. All these deaths occurred postpartum. 
Case summary 
A young primigravida presented to hospital in spontaneous labour near term after an 
uneventful pregnancy. Hypertension, low platelets and raised liver enzymes were 
found when she presented in labour; there had been no recorded hypertension prior to 
labour. Control of her blood pressure was problematic during labour, and became more 
difficult postpartum. She collapsed on the first postpartum day. Autopsy revealed an 
acute brain stem haemorrhage. Case review concluded that initial management of the 
hypertension on presentation in labour was sub-optimal. 
Summary 
Early recognition and appropriate management of pre-eclampsia saves women’s lives. 
Antenatal care should be oriented to ensuring that early signs of pre-eclampsia are not 
missed. Women with signs and symptoms of pre-eclampsia should be referred early for care 
by a specialist obstetrician. Each maternity unit should develop/adopt protocols for the 
management of hypertension in pregnancy and regularly audit their outcomes. Pre-
eclampsia does not necessarily resolve after birth and complications can occur at this time. 
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4.8 Early pregnancy deaths 
Early pregnancy maternal mortality 
For the purpose of this report, an early pregnancy death is defined as a maternal death 
during the first 14 weeks of pregnancy.  
There is no national collection of data regarding early pregnancy loss and information 
regarding these pregnancies is not routinely collected in the perinatal or hospital 
administrative data collections. The National Perinatal Data Collection only contains 
information on births of at least 20 weeks gestation (or greater than 400 grams birthweight).  
Equally, there is no national data collection on the conditions relating to termination of 
pregnancy. In Australia, legislation regarding termination of pregnancy varies across 
jurisdictions. The RANZCOG is supportive of the monitoring and collection of statistics 
relating to termination of pregnancy, including the occurrence of complications of these 
procedures. Non-availability of termination of pregnancy services has been shown to 
increase maternal morbidity and mortality in population studies (WHO 2004).  
The rate of ectopic pregnancy in the UK was found to be 11 per 1,000 pregnancies, with a 
maternal mortality of 0.2 per 1,000 estimated ectopic pregnancies (NICE 2012). Atypical 
presentation for ectopic pregnancy is common, from unexpected collapse with severe 
abdominal pain to a variety of pregnancy-related and apparently unrelated symptoms. In the 
event that trans-vaginal ultrasound shows an intrauterine sac of 25 mm or more without a 
fetal heart beat being visualised and/or a serum hCG level greater than or equal to 
1,500 IU/L, ectopic pregnancy should be actively excluded. 
Good practice guidance 
• An early pregnancy ultrasound that fails to identify a intrauterine sac in the presence 
of a positive serum hCG titre should stimulate active exclusion of tubal pregnancy 
(NICE 2012). 
Sources: NMMAC; NICE 2012. 
Early pregnancy deaths in 2008–2012 
There were 15 deaths that occurred in the first 14 weeks of pregnancy between 2008 and 
2012. The MMR for all deaths occurring in the first 14 weeks of pregnancy (15) is 1.0 per 
100,000 women who gave birth (Table 4.22). 
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Table 4.22: Early pregnancy deaths, 
Australia, 2000–2012 
Reporting period Number MMR(a) 
2000–2002 4 0.5 
2003–2005 6 0.8 
2006–2010(b) 15 1.0 
2008–2012(b) 15 1.0 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; 
previously 3-year reporting periods were used. 
Table 4.23 shows the MMR from early pregnancy deaths between 2000 and 2012. Five 
women died following an ectopic pregnancy and will be reported in this chapter. Ten of the 
early pregnancy deaths are reported and counted in other chapters, including 1 death related 
to psychosocial morbidity, 1 death from cardiovascular disease and 4 deaths from 
thromboembolism; 4 deaths were due to ‘other causes’.  
Table 4.23: Early pregnancy deaths, Australia, 2000–2012 
Cause of death  2000–2002 2003–2005 2006–2010(a) 2008–2012(a) 
Ectopic pregnancy 1 1 3 5(b) 
Psychosocial 0 2 5 1 
Cardiac 1 2 2 1 
Non-obstetric 
haemorrhage 1 0 1 0 
Thromboembolism 0 0 1 4 
Epilepsy 0 1 0 0 
Other  1 0 3 4 
Total 4 6(c) 15 15 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
(b) Includes 2 deaths from intra-abdominal haemorrhage secondary to surgery for ectopic pregnancy. 
(c) Number reported differs from those reported in Maternal deaths in Australia 2003–2005 due to 
differences in definitions used to determine an early pregnancy death. 
Five women died following an ectopic pregnancy (Table 4.24), including 2 who died from 
complications of the associated laparoscopic surgery. In 2 cases, delay in transfer to a facility 
able to provide appropriate care was noted as a consequence of the differential diagnosis of 
ectopic pregnancy not being considered initially.  
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Good practice guidance 
• The first clinical sign of an ectopic pregnancy may be a catastrophic collapse. 
• Ectopic pregnancy should be considered a possibility in any apparently healthy 
woman of reproductive age who collapses suddenly. 
• All maternity units, including those in rural settings, are recommended to have 
established guidelines for the management of a collapse associated with the ectopic 
pregnancy. Such guidelines should include access to blood products to assist 
resuscitation of associated severe haemorrhage. 
Source: NMMAC. 
Table 4.24: Early pregnancy deaths, Australia, 2008–2012 
Cause of death Maternal age group Parity(a) BMI(b) Smoking status Indigenous status 
Ectopic pregnancy 30–34 N  Not stated  Smoked Non–indigenous 
Ectopic pregnancy 35–39 M 27.7 Not stated  Non-indigenous 
Ectopic pregnancy(c) 25–29 N  19.6 Not stated  Non-indigenous 
Ectopic pregnancy 30–34 Not stated  Not stated  Not stated  Non-indigenous 
Ectopic pregnancy(c) 25–29 M 26.6 Did not smoke Non-indigenous 
Pulmonary thromboembolism 35–39 M 35.3 Did not smoke Not stated 
Pulmonary thromboembolism 25–29 N  Not stated  Not stated  Not stated 
Pulmonary thromboembolism 25–29 M Not stated  Not stated  Non-indigenous 
Pulmonary thromboembolism >40 N  Not stated  Not stated  Not stated 
Infective endocarditis 20–24 N  19.7 Smoked Indigenous  
Freshwater drowning 35–39 N  Not stated  Did not smoke Non-indigenous 
Intractable cerebral hypertension 35–39 Not stated  Not stated  Not stated  Indigenous  
Suicide 20–24 Not stated  Not stated  Not stated  Indigenous  
Unclassified 35–39 Not stated  23.1 Not stated  Non-indigenous 
Undetermined >40 M 44.0 Not stated  Not stated 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara. 
(b) BMI = body mass index. 
(c) Death from intra-abdominal haemorrhage secondary to surgery for ectopic pregnancy. 
Case summary 
Several months after the birth of her most recent baby, a multipara woke with 
abdominal pain. The day before, she had a weak positive result to a home pregnancy 
test. The pain rapidly escalated and she collapsed; when paramedics arrived, they were 
not able to resuscitate her. Autopsy revealed a massive intra-abdominal haemorrhage 
secondary to a ruptured tubal ectopic pregnancy. There were no potentially avoidable 
factors found. 
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Summary 
Although ectopic pregnancies are rare, they are potentially fatal. Women who do not know 
they are pregnant may present to medical or ambulance services with a catastrophic collapse, 
and the resuscitation decisions involve difficult decisions relating to the unexpected 
hypovolaemic cause of the collapse in a young woman with no external blood loss. An early 
pregnancy ultrasound that fails to identify an intrauterine sac in the presence of a positive 
serum hCG titre should stimulate active exclusion of tubal pregnancy; the presence of a 
small intrauterine sac does not exclude ectopic pregnancy. 
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4.9 Amniotic fluid embolism 
Amniotic fluid embolism (AFE) is a rare, but often fatal, condition of pregnancy and occurs 
when amniotic fluid enters the maternal circulation. Although originally thought to result 
from fetal skin cells or meconium in the amniotic fluid causing platelet thrombi to form 
blocking the pulmonary vessels (Medforth et al. 2011), it has more recently been postulated 
that immune-based mechanisms are involved in triggering the severe physiological changes 
that occur in the pulmonary circulation (McDonnell et al. 2013). Severe disseminated 
intravascular coagulopathy, leading to a dysfunctional failure of the woman’s clotting 
system, is a major component of this potentially lethal condition. 
Amniotic fluid embolism-related maternal mortality 
The diagnosis of AFE is difficult and often based on a process of exclusion. The difficulties 
with identifying AFE, and the small number of cases, mean that it is challenging to study 
and there is limited information available about this disease. In the absence of an autopsy in 
the instance of a maternal death, it may be difficult to distinguish AFE from other causes of 
maternal collapse in pregnancy, such as pulmonary embolism. 
A review of available data sources on the incidence of AFE internationally found a reported 
incidence of AFE ranging from 1.9 cases per 100,000 maternities in the UK to 6.1 per 100,000 
women who gave birth in Australia. Maternal mortality ratios ranged from 0.4 per 100,000 
live births in the Netherlands from 1993–2005 to 1.3 per 100,000 live births in the United 
States in 1997–2001 and 1.1 in Australia (excluding Victoria) in 1994–2005. Case-fatality rates 
ranged from 11% to 43%. Older maternal age and induction of labour were consistently 
associated with AFE (Knight et al. 2012).   
Although approximately two-thirds of women and their babies survive AFE, studies show 
that many of these women go on to develop serious morbidity (Knight et al. 2012; Roberts et 
al. 2010). Cerebral injury was noted in 6% of women with AFE in the UK, and cerebral 
infarction occurred in 20% of women in New South Wales (Knight et al. 2012). There is, 
however, limited information available on the long-term effects on women who survive.  
A recent article published in association with the AMOSS study on AFE, which was 
undertaken in Australia and New Zealand for the period 2010–2012, suggests that the 
incidence of maternal death from AFE is decreasing, and questions whether this change is 
related to improved recognition and improved care in the acute setting (McDonnell et al. 
2013). 
Good practice guidance 
• The immediate management of women with suspected AFE is prompt 
cardiopulmonary resuscitation and coagulation support by a multidisciplinary team, 
and should be undertaken in the same manner as for any other cause of collapse with 
coagulation failure (RCOG 2011b).  
Sources: NMMAC; RCOG 2011b. 
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Deaths from amniotic fluid embolism in 2008–2012 
In Australia, the death rate from AFE remained relatively stable over the period 2000–2010; 
however, there were only 4 deaths in the period 2008–2012, giving an MMR of 0.3 per 
100,000 women who gave birth (Table 4.25). All of these deaths were classified as direct 
maternal deaths. A similar MMR (0.33 per 100,000 maternities) was reported in the UK for 
the years 2010–2012 (Knight et al. 2014). 
Table 4.25: Maternal deaths from amniotic 
fluid embolism, Australia, 2000–2010  
 Reporting period Number MMR(a) 
2000–2002 10 1.3  
2003–2005 8 1.0 
2006–2010(b) 9 0.6 
2008–2012(b) 4 0.3 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; previously 
3-year reporting periods were used. 
Table 4.26 shows the type of labour and type of birth for the women who died from AFE. 
The 4 women who died were aged between 23 and 35 and parity ranged from 0 to 2. All of 
the women who died with known gestational age were over 36 weeks gestation at the time of 
their death, and all died postpartum.  
There has been a suggested link between induction of labour and AFE (Roberts et al. 2010). 
Three of the 4 women who died had an induction of labour and prostaglandins were used in 
each case.  
Table 4.26: Maternal deaths from amniotic fluid embolism, Australia, 2008–2012 
Maternal 
age group Parity(a) BMI(b) 
Smoking 
status 
Indigenous 
status 
Timing of 
death 
Onset of 
labour 
Mode of 
birth 
20–24 N 20.2 
Did not 
smoke Non-Indigenous Intrapartum No labour 
Caesarean 
section 
35–39 M 
Not 
stated Not stated Non-Indigenous Intrapartum Spontaneous 
Vacuum 
extraction 
25–29 M 27.0 
Did not 
smoke Not stated Postpartum Induced Forceps 
35–39 M 
Not 
stated Not stated Not stated Postpartum Induced 
Caesarean 
section 
(a) Parity is denoted by the following abbreviations: N = nullipara; M = multipara.  
(b) BMI = body mass index. 
The diagnosis of AFE can be difficult and is often one of exclusion or identified at the 
autopsy (Knight et al. 2012; Roberts et al. 2010; Tuffnell 2002). However, despite the 
difficulties, in many cases a characteristic series of events is highly suggestive of the 
diagnosis (see box below). Early recognition and immediate resuscitation of women with 
suspected AFE are essential to survival. Prompt caesarean section following collapse may be 
required to facilitate adequate cardiopulmonary resuscitation. 
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Characteristics of amniotic fluid embolism 
Most are likely to occur during labour and birth. 
Signs and symptoms include: 
•  dyspnoea 
•  restlessness, panic, feeling cold, paraesthesia 
•  sudden unexpected collapse. 
Findings on investigation: 
•  disseminated intravascular coagulation 
• chest X-ray: pulmonary oedema, adult respiratory distress syndrome, right atrial 
enlargement, prominent pulmonary artery. 
 
Case summary 
A multiparous woman had labour induced for post-dates after an uneventful 
pregnancy. She suffered sudden catastrophic collapse in labour. An immediate 
caesarean section was performed to assist with cardiopulmonary resuscitation. Severe 
PPH in association with disseminated intravascular coagulopathy followed. Despite 
appropriate resuscitation and massive blood product replacement, death subsequently 
occurred in an intensive care unit. The cause of death was AFE, confirmed by the 
finding of fetal debris in the pulmonary circulation at autopsy. No potentially avoidable 
factors were found on review. 
Diagnosing amniotic fluid embolism 
Three of the 4 women who died of AFE had an autopsy; the family of the fourth woman did 
not consent to an autopsy. AFE was confirmed at autopsy for the 3 cases, all by the presence 
of fetal squames in the maternal pulmonary circulation.  
Good practice guidance 
• Autopsy should be advocated in all deaths suspected of being caused by AFE. 
Sources: NMMAC; RCOG 2011b. 
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Summary  
AFE, one of the most common causes of direct maternal death in previous report periods in 
Australia, remains a poorly understood cause of maternal deaths. The persistence of AFE as 
a cause of direct maternal death is unlikely to change in light of current knowledge. Given 
the unexpected nature of AFE, it would be wise for maternity services to ensure that they 
have readily accessible guidelines for immediate management, and that they regularly 
undertake AFE management training. A high index of suspicion of AFE should be 
considered if there are signs of respiratory distress, restlessness and altered behaviour 
indicative of cerebral hypoxia. Early and aggressive resuscitation provides the best chance of 
survival. Autopsy is the gold standard of diagnosis in fatal AFE, and should be sought 
whenever maternal death follows unexpected collapse.   
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4.10 Anaesthesia-related deaths and deaths due to 
other causes  
Anaesthesia-related deaths  
There were 2 anaesthetic-related deaths during 2008–2012. The most common reasons for 
anaesthesia to be administered during labour or birth are for caesarean section and for pain 
relief in labour (usually by epidural injection).  
A multiparous woman with a high BMI suffered a cardiac arrest in a recovery unit following 
a second trimester termination of pregnancy. She developed global cerebral ischaemia and 
further treatment was withdrawn. The relevant state maternal mortality committee 
considered that failure to provide an adequate airway and adequate ventilation were 
potentially avoidable factors. 
The only information that was available regarding the second woman, due to legislative 
restrictions on that state’s maternal mortality committee, was that she died as a consequence 
of cerebral oedema and that craniostenosis was present and relevant. 
Although 43 of the 105 (41%) women who died in 2008–2012 gave birth by caesarean section, 
only 1 death (the woman above with craniostenosis) was thought to be anaesthetic-related. A 
death that occurred with cardiac arrest during a spinal anaesthetic was thought to be 
primarily associated with cardiovascular disease. The cause of death of these 43 women is 
shown in Table 4.27.  
Table 4.27: Cause of direct and indirect 
deaths of women who gave birth by 
caesarean section, Australia, 2008–2012 
Cause of death 
Number of 
cases 
Cardiovascular 8 
Non-obstetric haemorrhage 8 
Obstetric haemorrhage 7 
Hypertensive disorders 6 
Sepsis (including H1N1 influenza) 4 
Thromboembolism 3 
Amniotic fluid embolism 2 
Psychosocial 2 
Other 2 
Anaesthetic related 1 
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Other deaths 
There were 5 deaths due to ‘other’ causes between 2008 and 2012, with an MMR of 0.3 per 
100,000 women who gave birth (Table 4.28).  
Table 4.28: Maternal deaths from ‘other’ causes, 
Australia, 2000–2012  
 Reporting period Number MMR(a) 
2000–2002 10 1.3  
2003–2005 8 1.0 
2006–2010(b) 9 0.6 
2008–2012(b) 5 0.3 
(a) Per 100,000 women who gave birth. 
(b) 2006–2010 and 2008–2012 are 5-year periods; previously 
3-year reporting periods were used. 
Table 4.29 shows causes of death and classification of deaths from ‘other’ causes between 
2008 and 2012. These 5 cases are summarised below: 
• A morbidly obese woman in her 40s with mastitis and sleep apnoea died of an 
undetermined cause.  
• A woman in her mid-30s developed multi-organ failure in association with acquired 
haemolytic anaemia and postpartum coagulation defects.  
• A woman in her early 30s died of a malignancy that was diagnosed late due to 
inadequate antenatal care and investigation of her abdominal pain.  
• A teenage woman with severe asthma died, having not had any specialist review 
regarding management of asthma treatment during pregnancy. 
• A woman with epilepsy in her mid-30s died in her bath by drowning. This woman was 1 
of 3 highlighted in the Maternal deaths in Australia 2006–2010 report (AIHW et al. 2014). 
Table 4.29: Maternal deaths from other causes, Australia, 2008–2010  
Maternal age 
group 
Principal cause of 
death Contributing cause of death 
Gestation at 
death (weeks) 
Classification 
of death 
≥40 Undetermined Mastitis, obesity, sleep apnoea 6 Indirect 
35–39 Multi-organ failure 
Acute renal failure, postpartum 
coagulopathy, acquired haemolytic anaemia 35 Indirect 
30–34 Cancer None 38 Indirect 
<20 Asthma Not stated 20 Indirect 
35–39 Freshwater drowning Epilepsy 13 Indirect 
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Case summary 
An older woman suffered a sudden cardiac death at home in early pregnancy. Her husband 
administered cardiopulmonary resuscitation (CPR) and paramedics found her to be in 
ventricular fibrillation. Treatment by the paramedics resulted in reversion to a normal 
cardiac rhythm. Despite prolonged CPR and subsequent brain injury management in 
intensive care, there was no recovery of brain function. Autopsy found bilateral cerebral 
infarcts consistent with hypoxic ischaemic brain injury and some minor abnormalities in her 
heart. Because this death was unexplained, the death could not be classified, though the 
most likely direct cause of death was a cardiac arrhythmia. There were no potentially 
avoidable factors found. 
Summary 
Two deaths were associated with anaesthesia: 1 for termination of pregnancy and 1 for 
caesarean section. Forty-two other maternal deaths where the woman gave birth by 
caesarean section had other specific causation. 
There were 5 ‘other’ maternal deaths caused by asthma, epilepsy, cancer, acquired 
haemolytic anaemia and undetermined causation in a morbidly obese woman with sleep 
apnoea.  
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5 Aboriginal and Torres Strait Islander 
women 
The MMR for the period 2008–2012 for Aboriginal and Torres Strait Islander women was 
more than double that for non-Indigenous women (including those where Indigenous status 
was unknown), with MMRs of 13.8 and 6.6 deaths, respectively, per 100,000 women who 
gave birth (risk ratio 2.09; 95% confidence limits 1.02–4.30). Caution should be used when 
interpreting these results due to the small number of deaths on which these calculations are 
based. 
5.1 Aboriginal and Torres Strait Islander maternal 
deaths in 2008–2012 
There were 12 Aboriginal and Torres Strait Islander women who died during their 
pregnancy, labour or in the postnatal period between 2008 and 2012. Of these, 8 were 
maternal deaths and 4 were incidental deaths.  
In 23 of the 2008–2012 maternal deaths (including 17 direct and indirect deaths), Indigenous 
status was not known. 
The 8 maternal deaths among Aboriginal and Torres Strait Islander women in the current 
reporting period comprised 4 direct maternal deaths and 4 indirect maternal deaths. Table 
5.1 presents a summary of maternal deaths in Aboriginal and Torres Strait Islander women 
between 2008 and 2012. 
Table 5.1: Maternal deaths in Aboriginal and Torres Strait Islander women, Australia, 2008–2012 
Cause of death 
Maternal 
death 
classification 
Maternal 
age group Parity(a) BMI(b) 
Smoking 
status 
Timing of 
death Mode of birth 
Psychosocial Indirect 20–24 
Not 
stated 
Not 
stated Not stated 
Early 
pregnancy 
Termination of 
pregnancy 
Sepsis Direct 20–24 M 27.1 Smoked Postpartum 
Caesarean 
section 
Sepsis Direct ≥40 GM 36.7 Not stated Postpartum 
Birth at term; 
mode not 
stated 
Early pregnancy 
death Indirect 35–39 
Not 
stated 
Not 
stated Not stated 
Early 
pregnancy 
Normal 
vaginal birth 
Anaesthesia-
related death Direct ≥40 GM >30.0  Not stated 
Mid- 
pregnancy 
Mid-trimester 
termination of 
pregnancy 
Cardiovascular Direct 20–24 M 32.9 
Did not 
smoke Postpartum 
Normal 
vaginal birth 
Cardiovascular Indirect 20–24 P 19.7 Smoked 
Early 
pregnancy 
No birth 
occurred 
Psychosocial Indirect <20 P 22.2 Smoked Antepartum 
No birth 
occurred 
(a) Parity is denoted by the following abbreviations: P = primipara, M = multipara; GM = grand multipara  
(b) BMI = body mass index. 
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The median age of the Aboriginal and Torres Strait Islander women who died was 23.5, 
compared with the median age of the non-Indigenous women who died (including those 
‘not stated’) of 32. All 6 women for whom parity was known were parous, with 2 being 
grand multipara (4 or more previous births).  
Three deaths were related to early pregnancy events. One was an Aboriginal and Torres 
Strait Islander woman in her 30s who died from intractable intracerebral hypertension 
following a ruptured cerebral aneurysm. The second was a young woman who developed 
cardiac failure and bronchopneumonia associated with infective endocarditis. The third was 
a woman in her 20s who committed suicide 4 weeks after a termination of pregnancy in 
association with significant substance abuse. 
One woman who died was an obese multipara who suffered cardiac arrest in the recovery 
room following a mid-trimester termination of pregnancy. 
A young woman with a known history of depression committed suicide late in pregnancy. 
No health-care preventable factors were found during a State and Territory Maternal 
Mortality Committees (STMMC) review of this death. 
The 3 postpartum deaths included 2 septic direct deaths: 1 due to a streptococcal 
endometritis and the other to a toxic shock-like syndrome secondary to cholecystitis. The 
third death was an obese woman in her 20s who developed a lethal peripartum 
cardiomyopathy secondary to a Haemophilus influenza infection in late pregnancy. 
Trends in maternal mortality by Indigenous status 
There were 8 maternal deaths of Aboriginal and Torres Strait Islander women during  
2008–2012 compared with 9 in 2006–2010 (Table 5.2).  
Table 5.2: Trends in maternal mortality in Aboriginal and Torres Strait Islander women and other 
Australian women, 1991–2012 
 
Maternal deaths in Aboriginal and 
Torres Strait Islander women 
 Maternal deaths in other Australian 
women(a)  
Period Direct Indirect MMR(b)  Direct Indirect MMR(b) Relative MMR(c) 
1991–1993 1 4 23.2  26 17 5.8 4.0 
1994–1996 3 1 17.4  43 19 8.3 2.1 
1997–1999 1 5 23.5  33 23 7.7 3.1 
2000–2002 4 8 45.8  28 44 10.0 4.6 
2003–2005 2 4 21.7  27 32 8.0 2.7 
2006–2010(d) 5 4 16.4  35 52 6.2 2.6 
2008–2012(d) 4 4 13.8  45 49 6.6 2.1 
(a) Other Australian women include women whose Indigenous status was not known. Previous reports have included women with missing 
Indigenous status together with those for non-Indigenous women. For consistency, this grouping has been applied to all periods. 
(b) MMR is reported per 100,000 women who have given birth. The number of Aboriginal and Torres Strait Islander women or other women 
who gave birth is the sum of numbers reported in Australia's mothers and babies for the years referenced. 
(c) Relative MMR is the ratio of the MMR for Aboriginal and Torres Strait Islander women to the MMR for other women who gave birth in 
Australia. No difference between groups will yield an MMR equal to 1.  
(d) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
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The MMR for Aboriginal and Torres Strait Islander women has been consistently higher than 
that for other Australian women (Figure 5.1). Maternal deaths in Australia reports have 
included women where Indigenous status was not reported along with women reported as 
non-Indigenous. These women are collectively referred to as ‘other Australian women’.  
Over the period 1991–1993 to 2008–2012, the MMR for Aboriginal and Torres Strait Islander 
women has fluctuated, but it is still unacceptably double that of other Australian women. 
Though there have been some small variations in the MMR for other Australian women, this 
rate has not changed significantly over this period. Fluctuations that do occur in the MMRs 
reflect both the rarity of maternal death and the smaller population of Aboriginal and Torres 
Strait Islander women. 
 
Figure 5.1: Maternal mortality rates for Aboriginal and Torres Strait Islander women compared 
with ’other Australian women’, 1991–2012 
The causes of maternal death of Aboriginal and Torres Strait Islander women reported 
between 2000 and 2012 have been classified to categories of maternal death used in the 
current report. Cardiovascular conditions, psychosocial conditions and sepsis were the 
leading cause categories among Aboriginal and Torres Strait Islander women (Table 5.3). In 
contrast, the most common specific causes of death for other Australian women in this 
period were hypertensive disorders and non-obstetric haemorrhage, followed by 
cardiovascular conditions.  
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Table 5.3: Aboriginal and Torres Strait Islander maternal deaths, Australia, 
2000–2012 
Cause of death 2000–2002 2003–2005 2006–2010(a) 2008–2012(a) 
Amniotic fluid 
embolism 1 0 0 0 
Thrombosis and 
thromboembolism 1 0 0 0 
Sepsis 1 0 3 2 
Cardiovascular 2 1 2 2 
Hypertensive disorder 1 2 1 0 
Obstetric 
haemorrhage 2 0 1 0 
Non-obstetric 
haemorrhage 1 0  0 
Psychosocial 3 1 1 2 
Early pregnancy  0 0 0 0 
Anaesthesia-related 0 0 0 1 
Other  0 2 1 1 
Total 12 6 9 8 
(a) 2006–2010 and 2008–2012 are 5-year periods; previously 3-year reporting periods were used. 
Cause-specific MMR (CS-MMR) is a measure of the risk of maternal death from specific 
conditions. These are shown for Aboriginal and Torres Strait Islander women and other 
Australian women in Figure 5.2 and Table 5.4, expressed per million women who gave birth. 
The relative CS-MMR quantifies the effect of Indigenous status on the risk of mortality from 
each cause. ‘Other specified cause’ comprises a varied group of conditions. Hypertensive 
disorders and non-obstetric haemorrhage were combined because these conditions may  
co-exist.  
The risk of maternal death from psychosocial conditions was fivefold higher among 
Aboriginal and Torres Strait Islander women compared with other Australian women for the 
period 2000–2012, and the risk of cardiovascular conditions was fourfold higher. Higher risks 
of maternal death from sepsis, obstetric haemorrhage, and hypertensive disorders and non-
obstetric haemorrhage combined, are also seen among Aboriginal and Torres Strait Islander 
women, compared with other women. 
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Note: HD&N-OH = Hypertensive disorders and non-obstetric haemorrhage. 
Figure 5.2: Cause of maternal death among Aboriginal and Torres Strait Islander women and other 
Australian women, 2000–2012  
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Table 5.4: Cause of maternal death among Aboriginal and Torres Strait Islander women and other 
Australian women, 2000–2012 
  
Maternal deaths in Aboriginal 
and Torres Strait Islander women 
 Maternal deaths in other 
Australian women(a) 
 
Cause of maternal death Number Per cent CS-MMR(b) 
 
Number Per cent CS-MMR(b) 
Relative 
CS-MMR(c,d) 
Cardiovascular conditions 7 22.6 52.7  45 15.3 13.1 4.0 
Psychosocial conditions 7 22.6 52.7  36 12.2 10.5 5.0 
Sepsis 4 12.9 30.1  32 10.8 9.3 3.2 
Hypertensive disorders and 
non-obstetric haemorrhage(e) 4 12.9 30.1 
 
49 16.6 14.3 2.1 
Other specified cause 4 12.9 30.1  55 18.6 16.1 1.9 
Obstetric haemorrhage  3 9.7 22.6  27 9.2 7.9 2.9 
Amniotic fluid embolism 1 3.2 7.5  29 9.8 8.5 0.9 
Thromboembolism 1 3.2 7.5  22 7.5 6.4 1.2 
Total 31 100.0 233.3  295 100 86.1 2.7 
(a) In this table ‘other Australian women’ include women whose Indigenous status was not known. Previous reports have variously reported 
maternal deaths with unknown Indigenous status together with those for non-Indigenous women. This limits the choice of comparator group. 
The MMR for ‘other Australians’ will be higher than for ‘non-Indigenous women’. 
(b) CS-MMR (cause-specific MMR) is derived using the deaths for the cause as the numerator and the number of women who gave birth as the 
denominator. It is reported per million women who gave birth. 
(c) Relative MMR measures the effect of Indigenous status on maternal mortality. This is derived by dividing the cause-specific MMR for 
Aboriginal and Torres Strait Islander women by the cause-specific MMR for other Australian women.  
(d) Statistically significant differences in the CS-MMR for Aboriginal and Torres Strait Islander women suggest that their mortality relative to 
other Australian women is not due to chance. This can be inferred if the 95% confidence limits for the relative MMR do not include 1.  
(e) Hypertensive disorders and non-obstetric haemorrhage are combined in this table because they tend to overlap. 
In comparison with non-Indigenous women, Aboriginal and Torres Strait Islander women 
more commonly die from pre-existing and chronic conditions. 
Good practice guidance 
• Antenatal care early in pregnancy is particularly important for Aboriginal and Torres 
Strait Islander women to ensure that there is provision to detect and appropriately 
manage chronic disease, and services need to be aware of the higher rates of 
depression and suicide risk in Aboriginal and Torres Strait Islander women compared 
with non-Indigenous women. 
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5.2 Identifying Aboriginal and Torres Strait Islander 
women 
Aboriginal and Torres Strait Islander status has been collected for cases categorised as direct 
maternal deaths since 1970, and for indirect maternal deaths and incidental deaths since 
1991. For this report, Aboriginal or Torres Strait Islander status was not reported for 
23 women who died during pregnancy or within 42 days of giving birth, including 17 direct 
or indirect maternal deaths, representing 22%of maternal deaths.  
An Aboriginal and Torres Strait Islander woman is defined for Australian health data 
collections as a woman of Aboriginal or Torres Strait Islander descent who identifies herself 
as such. For this report, information on Indigenous status was collected using the National 
Maternal Death Reporting (NMDR) form 2006–2010, using the standard categories.  
The quality of Aboriginal and Torres Strait Islander status data, as measured by the 
proportion of clients with a not-stated response in specific data collections, has improved in 
most data collections since the AIHW’s 2007 data quality report (AIHW 2012). Since the 2007 
report, a number of activities have been, or are being, undertaken to improve the 
identification of Indigenous people in the community services’ data collections. These 
include modifying client forms and client information management systems and the 
provision of staff training, including cultural awareness training, and training on how to 
collect Indigenous status data. 
Summary 
In this 5-year period, Aboriginal and Torres Strait Islander women were twice as likely to die 
during their pregnancy or the puerperium as other Australian women. Pre-existing and non-
obstetric conditions are more common causes of maternal death for Aboriginal and Torres 
Strait Islander women than for other women. Cardiovascular conditions, sepsis and 
psychosocial conditions were the leading cause categories of deaths among Aboriginal and 
Torres Strait Islander women between 2000 and 2012.  
Antenatal care early in pregnancy is particularly important for Aboriginal and Torres Strait 
Islander women to ensure that there is provision for early detection and appropriate 
management of chronic disease that may have an impact on pregnancy. 
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6 Incidental deaths 
6.1 Causes of incidental maternal deaths 
Incidental maternal deaths are deaths that happen to occur in pregnancy or the puerperium 
from causes unrelated to pregnancy. Internationally, cases of such incidental deaths are 
included in maternal mortality reporting, although only direct, indirect and unclassified 
deaths are counted for statistical purposes. In addition to the 105 maternal deaths reported to 
the NPESU between 2008 and 2012, there were 27 incidental maternal deaths (Table 6.1).  
Table 6.1: Causes of incidental maternal deaths, 
Australia, 2006–2012 
Cause of death  2006–2010 2008–2012 
Medical causes 11 11 
Motor vehicle accident 7 9 
Homicide 3 2 
Accidental injury 2 2 
Undetermined 2 2 
Overdose 1 1 
Total 26 27 
Incidental deaths resulting from motor vehicle accidents were the most common single 
cause, accounting for 9 of the 27 incidental maternal deaths. The incidental maternal deaths 
from medical causes were the most common category and included deaths due to a variety 
of conditions such as asthma, sepsis, malignancy, intracranial haemorrhage and probable 
cardiac arrhythmia consequent on the excessive use of stimulants. There were 2 deaths due 
to homicide, where the deaths were attributed to known partner violence; these were 
additional to the 2 indirect deaths due to homicide reported in ‘Section 4.2 Psychosocial’. 
Two accidental injury deaths, 1 overdose and 2 deaths due to undetermined causation were 
also reported. 
Summary 
All maternal deaths occurring in pregnancy or the puerperium should be reviewed by the 
relevant state or territory maternal mortality committee. Information on incidental maternal 
deaths is needed to inform prevention strategies. Motor vehicle accidents during pregnancy 
are a major cause of traumatic fetal mortality and serious maternal injury. Correct maternal 
seatbelt use is to be advocated. 
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Appendix B: Data quality statement 
B.1 National Maternal Death Report Data Set 
Summary of key issues 
• The National Maternal Death Report Data Set provides national information for use in 
preparing a national report on women who died while pregnant or within 42 days of 
termination of pregnancy, between 2008 and 2012. 
• Data sources, supply and quality varied considerably by state and territory. 
• Legislative privacy restrictions and data approval processes differed by state and 
territory, and in some jurisdictions precluded full supply of maternal death data. 
• Not all states and territories had active maternal mortality committees or subcommittees 
for the period of deaths. This has limited the quality and completeness of data supplied. 
• National data were published less than 1 year after collection by the National Perinatal 
Epidemiology and Statistics Unit (NPESU) and within 3 years of the time frame for 
including maternal deaths of 31 December 2012. 
• Data collection for some jurisdictions were retrospective and not from existing 
collections. Retrospective data collection limited the quality and completeness of data 
supplied. 
• Methodology, definitions, classifications and reference periods for maternal death data 
collections differ significantly across states and territories, and comparisons between 
collections should be made with caution. 
Description 
The National Maternal Death Report Data Set (NMDRDS) is an ad-hoc national research data 
set collated from state and territory sources to be used in the preparation of the national 
report. The data set contains information on the deaths of women reported to have died 
while pregnant or within 42 days of termination of pregnancy, between 2008 and 2012. Data 
were supplied by state and territory health authorities to the NPESU. The data supplied by 
states and territories were primarily compiled from state and territory maternal death data 
collections or, where not available, other data sources. Data in the NMDRDS include data 
collected retrospectively and specifically by some states and territories to produce the 
maternal deaths report for 2008–2012. The state and territory health authorities receive 
clinical data on the women who died from patient administrative and clinical records, as 
well as from the state and territory maternal mortality committees or subcommittees where 
death reviews are undertaken. This information is usually collected through a variety of 
sources, including notifications from health professionals involved in the case, coronial 
reports and notifications from related data collections, including the jurisdictional register of 
births, deaths and marriages. States and territories use these data to determine cause of 
death, classification of death and for service planning, monitoring and internal and public 
reporting.  
The organisational structure, roles and responsibilities of State and Territory Maternal 
Mortality Committees (STMMC) vary across states and territories. There is no standardised 
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method of identifying and collecting data on maternal deaths, and no nationally agreed 
process of reporting or investigation. Data from the NMDRDS, used to populate this report, 
reflect these inconsistencies.  
States and territories supplied these data subject to national and jurisdictional ethics 
committee approvals. Ethics approval for this study was obtained from the: Australian 
Institute of Health and Welfare Human Research Ethics Committee (HREC); New South 
Wales Population Health HREC; Consultative Council on Obstetric and Paediatric Mortality 
and Morbidity HREC; Queensland Health HREC; Western Australia Department of Health 
HREC; Western Australian Aboriginal Health Ethics Committee; South Australia Health 
HREC; Health and Medical HREC, University of Tasmania; Australian Capital Territory 
Department of Health HREC; Northern Territory Department of Health and Menzies School 
of Health Research HREC; Aboriginal Health Research Ethics Committee, the National 
Coronial Information Service HREC; and the University of New South Wales HREC. 
Institutional environment 
The NPESU was established in 1979 to provide information and statistics in reproductive 
and perinatal health. The Unit is part of the University of New South Wales (UNSW) and is 
located at the Randwick Hospitals Campus, and since 1987 has been a collaborating unit of 
the Australian Institute of Health and Welfare (AIHW).  
The AIHW is a major national agency set up by the Australian Government under the 
Australian Institute of Health and Welfare Act 1987 to provide reliable, regular and relevant 
information and statistics on Australia’s health and welfare. It is a corporate Commonwealth 
entity established in 1987, governed by a management board, and accountable to the 
Australian Parliament through the Health portfolio. 
The AIHW aims to improve the health and wellbeing of Australians through better health 
and welfare information and statistics. It collects and reports information on a wide range of 
topics and issues, ranging from health and welfare expenditure, hospitals, disease and 
injury, and mental health to ageing, homelessness, disability and child protection. 
The Institute also plays a role in developing and maintaining national metadata standards. 
This work contributes to improving the quality and consistency of national health and 
welfare statistics. The Institute works closely with governments and non-government 
organisations to achieve greater adherence to these standards in administrative data 
collections to promote national consistency and comparability of data and reporting. 
One of the main functions of the AIHW is to work with the states and territories to improve 
the quality of administrative data and, where possible, to compile national data sets based on 
data from each jurisdiction, to analyse these data sets and disseminate information and 
statistics. 
The Australian Institute of Health and Welfare Act 1987, in conjunction with compliance to the 
Privacy Act 1988 (Cwlth), ensures that the data collections managed by the NPESU are kept 
securely and under the strictest conditions with respect to privacy and confidentiality. 
For further information, see the AIHW website <www.aihw.gov.au>. 
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Timeliness 
The NMDRDS is a report-specific ad-hoc data collection used to prepare the intended 
national report. Data are published in the Maternal deaths in Australia series. National data 
were published less than 1 year after collection of the data by the AIHW, and within 3 years 
of the time frame for including maternal deaths of 31 December 2012. 
Accessibility 
The NPESU provides a variety of products that draw upon the NMDRDS. Published 
products available are: 
• Maternal deaths in Australia series 
• Maternal mortality: data linkage methodology—foundations for enhanced maternity data 
collection and reporting in Australia: National Maternity Data Development Project Stage 1 
(publication second half 2015). 
Data are also used in a number of other AIHW products including Australia’s health and the 
Australia’s mothers and babies series. Data are subject to strict confidentiality restrictions due to 
the small number of deaths and potential for identification, and is not generally available on 
request. In accordance with the HREC approvals, these data will be kept for 7 years from the 
date of report publication and will then be destroyed. 
Interpretability 
The organisational structure, including relevant legislation, policy and process for maternal 
death data collection, varies by state and territory. The NMDRDS reflects these variations. In 
all cases, the best available information was used to form the NMDRDS. Data provided by 
Western Australia has been subject to legislative privacy restrictions, and limited 
information was initially provided to the NPESU. Data as collected by the Western 
Australian Perinatal and Infant Mortality Committee were not provided and data were 
sourced from the Department of Health, Western Australia perinatal and hospital 
administrative data collections. Classification of death, as decided by the Maternal Mortality 
Committee, was subsequently supplied at a later date for some cases. During the 
development of the report, the New South Wales Maternal and Perinatal Committee were 
out of term and a number of cases were provided to the NPESU as not yet reviewed by the 
New South Wales Maternal and Perinatal Committee. For some cases, only very limited 
information was available. 
An overview of each state’s maternal death data collection process is outlined below: 
• The New South Wales Ministry of Health is notified of maternal deaths through a 
variety of organisations and methods, including hospitals, the Department of Forensic 
Medicine at Glebe, Ministry of Health systematic searches of New South Wales 
population health data sets (e.g. Admitted Patient Data Collection and the New South 
Wales Perinatal Data Collection) and through the National Coronial Information System. 
The number of maternal deaths for each year is assessed against Australian Bureau of 
Statistics (ABS) mortality data, where available (deaths with an International Statistical 
Classification of Diseases and Related Health Problems, 10th edition (ICD-10) cause of 
death code commencing with an ‘O’) to maximise ascertainment.  
• In Victoria, maternal deaths are identified through direct notification by health services, 
Victorian Perinatal Data Collection Unit (birth forms), the Coroner’s Office, the Registrar 
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of Births, Deaths and Marriages and through media reports. In 2010, automatic electronic 
notification through coronial e-Medical Deposition Form was introduced.  
• Queensland Health conducts dedicated searches of hospital administrative data sets 
intended for the sole purpose of identifying maternal deaths. In 2012, the Minister of 
Health approved consideration of changes to the Public Health Act 2005 to mandate 
reporting of maternal deaths to the Department (working with the Queensland Maternal 
and Perinatal Quality Council). 
• South Australia Health has no formal process of maternal death notification in place. The 
Maternal Mortality Committee accesses multiple notifications, including review of media 
articles, word of mouth, clinicians, pathologists and sentinel event reporting from 
hospitals. Although there is a tick box on death certificates to indicate if a woman has 
been pregnant in the last 3 months, this has never been a source of notification to the 
Maternal Mortality Committee of a maternal death. Hospital separation discharge codes 
are also reviewed as a quality check to identify maternal deaths. However, to date, this 
process has never informed the Maternal Mortality Committee of a maternal death the 
Committee was not already aware of. Similarly, sentinel event reporting has not 
identified a new maternal death to this Committee. 
• The Tasmanian Department of Health and Human Services is notified of maternal deaths 
through the following sources: health statistics, the Register of Births, Deaths and 
Marriages and local clinicians who are members of the Tasmanian Council of Obstetric 
and Paediatric Mortality & Morbidity (COPMM) (state-wide) and local hospital 
Morbidity and Mortality Committees. 
• Information on the process of notification and data collection were not provided by the 
Australian Capital Territory Department of Health.  
Northern Territory Department of Health undertook a process of maternal death 
ascertainment and review specifically to supply data to the NMDRDS. 
Relevance 
The NMDRDS is a specification for data compiled primarily from state and territory 
maternal death data collections or, where not available, other data sources. Data were 
requested on the death of all women reported to have died while pregnant or within 42 days 
of termination of pregnancy in Australia in hospitals, birth centres and the community 
between 2008 and 2012. Information was collected from each state and territory health 
department through the completion of a standardised data collection form: the NMDR form 
2006–2010. Specifications for the NMDR form 2006–2010 were developed using nationally 
standardised data as entered into the National health data dictionary, which has an 
repository, METeOR—AIHW online metadata repository. It includes data items relating to 
the mother, including demographic characteristics and factors relating to the pregnancy, 
labour and birth; details of death; classification of death and data items relating to the baby, 
including birth status; and any additional case summaries. 
A National Maternal Mortality Advisory Committee (NMMAC) was convened to oversee the 
process of data collection for the maternal death report. A subcommittee of the NMMAC, the 
National Maternal Mortality Advisory Committee—Report Working Group, was established 
to oversee the development of NMDR form 2006–2010 and a system of maternal death 
classification.  
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The NMDR form 2006–2010 was limited in the information that could be collected due to the 
retrospective data collection and advice from states and territories regarding availability of 
data. NMMAC revised the process for data collection for the maternal death report for the 
years 2011 and 2012, with NMDR form 2011–2012, as part of a broader project to produce a 
uniform National Maternal Death Reporting form for use by clinicians reporting deaths to 
the jurisdictional STMMC. 
Accuracy 
Inaccurate responses may occur in all data provided to the NPESU. The NPESU does not 
have direct access to maternal mortality committee records to determine the accuracy of the 
data provided. However, the NPESU undertakes validation on receipt of data. Data received 
from states and territories are checked for completeness, validity and logical errors. Potential 
errors are queried with jurisdictions, and corrections and resubmissions are made in 
response to these edit queries. Any cases without outstanding issues are reviewed by the 
NMMAC. The NPESU does not adjust data to account for possible data errors. 
Errors may occur during the processing of data by the states and territories or at the NPESU. 
Processing errors prior to data supply may be found through the validation checks applied 
by the NPESU. The data are corrected when verification of an error was supplied. 
The NPESU does not adjust the data to correct for missing values.  
Prior to publication, data are referred back to jurisdictions for checking and review. Note 
that because of data editing and subsequent updates of state/territory information, numbers 
reported may differ from those in reports published by the states and territories. 
Coherence 
The NMDRDS is a one-off data set collected specifically for use in Maternal deaths in Australia 
2008–2012. Similar data sets have been compiled for previous reports in the Maternal deaths in 
Australia series. Although definitions and some individual data elements have changed over 
time in response to expert review, changes in international definitions and coding relating to 
maternal deaths, in many cases it is possible to map these changes and make meaningful 
comparisons over time. However, due to the overlapping time periods in the Maternal deaths 
in Australia 2006-2010 and Maternal deaths in Australia 2008–2012 reports, caution should be 
used in interpreting recent trends.  
State and territory health authorities compile statistics and publish reports on maternal 
deaths. Methodology, definitions, classifications and reference periods for these collections 
differ significantly across states and territories, and comparisons between states and 
territories should be made with caution. 
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Appendix C: Ethics approval 
Human research ethical approval for compilation of the research data set and Maternal deaths 
in Australia 2006–2010 report (AIHW et al. 2014) was obtained from the following Human 
Ethics Research Committees (HRECs), and has been extended to cover the period 2011–2012: 
• The Australian Institute of Health and Welfare Ethics Committee  
• The University of New South Wales Human Research Ethics Committee 
• The Consultative Council on Obstetric and Paediatric Mortality and Morbidity 
(Victoria) 
• New South Wales Population Health Services Research Ethics Committee  
• Government of Western Australia, Department of Health, Human Research Ethics 
Committee 
• Government of South Australia, SA Health, Human Research Ethics Committee 
• Queensland Government, Queensland Health, Human Research Ethics Committee, 
Centre for Healthcare Improvement 
• University of Tasmania, Human Research Ethics Committee (Tasmania) Network  
• Human Research Ethics Committee of Northern Territory, Department of Health and 
Menzies School of Health Research  
• The National Coronial Information System, Department of Justice, Human Research 
Ethics Committee   
• Australian Capital Territory, Department of Health, ACT Health Human Research 
Ethics Committee 
In satisfaction of the conditions of the ethics approval from the Australian Capital 
Territory, it is noted that the Australia Capital Territory Health’s Directorate Human 
Research Ethics Committee approved this project on 8 February 2012. 
Aboriginal Health Ethics Committee approval was sought from states and territories where a 
separate committee or subcommittee was established. Approval was obtained from:  
• Aboriginal Health Council of South Australia, Aboriginal Health Research Ethics 
Committee 
• Western Australian Aboriginal Health Ethics Committee 
• Northern Territory Department of Health and Menzies School of Health Research 
Aboriginal Ethics Sub Committee. 
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Glossary 
Aboriginal and Torres Strait Islander: A person of Aboriginal and/or Torres Strait Islander 
descent who identifies as an Aboriginal and/or Torres Strait Islander. See also Indigenous. 
acute: Coming on sharply and often brief, intense and severe. 
administrative data collection: A data set that results from the information collected for the 
purposes of delivering a service or paying the provider of the service. This type of collection 
is usually complete (i.e. all in-scope events are collected), but it may not be fully suitable for 
population-level analysis because the data are collected primarily for an administrative 
purpose. An example is the Alcohol and Other Drug Treatment Services National Minimum 
Data Set.  
amniotic fluid embolism (AFE): A rare obstetric emergency in which it is postulated that 
amniotic fluid, fetal cells, hair or other debris enter the maternal circulation, causing 
cardiorespiratory collapse. 
antenatal: The period covering conception up to the time of birth. Synonymous with 
prenatal. 
arrhythmia: A disturbed rhythm of the heartbeat—too fast, too slow or irregular. 
assisted reproductive technology: Treatments or procedures that involve the in vitro 
handling of human oocytes (eggs) and sperm or embryos for the purposes of establishing a 
pregnancy. 
asthma: A common, chronic inflammatory disease of the air passages that presents as 
episodes of wheezing, breathlessness and chest tightness due to widespread narrowing of 
the airways and obstruction of airflow. The symptoms may reverse without treatment, but 
often treatment is required. Different medications can prevent the episodes or relieve them. 
atherosclerosis: A process in which fatty and fibre-like deposits build up on the inner walls 
of arteries, often forming plaques that can then cause blockages. It is the main underlying 
condition in heart attack, angina, stroke and peripheral vascular disease. 
birth status: Status of the baby immediately after birth. 
birthweight: The first weight of the baby (stillborn or liveborn) obtained after birth (usually 
measured to the nearest 5 grams and obtained within 1 hour of birth). 
blood pressure: The force exerted by the blood on the walls of the arteries as it is pumped 
around the body by the heart. It is written, for example, as 134/70 mmHg, where the upper 
number is the systolic pressure (the maximum force against the arteries as the heart muscle 
contracts to pump the blood out) and the lower number is the diastolic pressure (the 
minimum force against the arteries as the heart relaxes and fills again with blood). Levels of 
blood pressure can vary greatly from person to person and from moment to moment in the 
same person.  
body mass index (BMI): The most commonly used method of assessing whether a person is 
normal weight, underweight, overweight or obese (see obesity). It is calculated by dividing 
the person’s weight (in kilograms) by their height (in metres) squared; that is, kg ÷ m2. For 
both men and women, underweight is a BMI below 18.5, acceptable weight is from 18.5 to 
less than 25, overweight is from 25 to less than 30, and obese is 30 and over. Sometimes 
overweight and obese is combined, and is defined as a BMI of 25 and over. 
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caesarean birth (also caesarean section or c-section): A method of birth in which a surgical 
incision is made into the mother’s womb via the abdomen to directly remove the baby.  
cholecystitis: Inflammation of the gallbladder. 
chorioamnionitis: An inflammation, usually from an infection, of the membranes 
surrounding the fetus. 
confidence interval (CI): A statistical term describing a range (interval) of values within 
which we can be ‘confident’ that the true value lies, usually because it has a 95% or higher 
chance of doing so. 
diabetes (diabetes mellitus): A chronic condition in which the body cannot properly use its 
main energy source: the sugar glucose. This is due to a relative or absolute deficiency in 
insulin: a hormone that is produced by the pancreas and helps glucose enter the body’s cells 
from the bloodstream and then be processed by them. Diabetes is marked by an abnormal 
build-up of glucose in the blood, and it can have serious short- and long-term effects.  
eclampsia: The occurrence of 1 or more convulsions not caused by other conditions, such as 
epilepsy or cerebral haemorrhage, in a woman with pre-eclampsia. The onset of convulsions 
may be preceded by a sudden rise in blood pressure and/or a sudden increase in oedema 
and development of oliguria. 
ectopic pregnancy: The development of a fetus at a site other than in the uterus. This may 
happen if the fertilised egg cell remains in the ovary or in the tube leading from near the 
ovary to the uterus (the Fallopian tube), or if it lodges in the free abdominal cavity. 
embolism: The condition in which an embolus becomes lodged in an artery and obstructs its 
blood flow. The most common form of embolism is pulmonary embolism, in which a blood 
clot is carried in the circulation to lodge in the pulmonary artery.  
epilepsy: A disturbance of brain function marked by recurrent fits and loss of consciousness.  
factor V Leiden deficiency: a genetically inherited disorder of blood clotting that causes an 
increase in blood clotting (thrombophilia). 
fetal death (stillbirth): Death before the complete expulsion or extraction from its mother of 
a product of conception of 20 or more completed weeks of gestation or of 400 grams or more 
birthweight. The death is indicated by the fact that after such separation, the fetus does not 
breathe or show any other evidence of life, such as beating of the heart, pulsation of the 
umbilical cord or definite movement of voluntary muscles. 
gestational age: The duration of pregnancy in completed weeks calculated from the date of 
the first day of a woman’s last menstrual period and her baby’s date of birth, or via 
ultrasound, or derived from clinical assessment during pregnancy or from examination of 
the baby after birth. 
gestational diabetes: A form of diabetes that is first diagnosed during pregnancy (gestation). 
It may disappear after pregnancy but signals a high risk of diabetes occurring later on. 
grand multipara: Pregnant woman who has had 4 or more previous pregnancies resulting in 
a live birth or stillbirth. 
haemorrhage (bleeding): The escape of blood from a ruptured blood vessel, externally or 
internally. 
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HELLP syndrome: A severe complication of pre-eclampsia characterised by Haemolysis, 
Elevated Liver enzymes and Low Platelet count; the syndrome name is an abbreviation of 
the 3 main features of the syndrome. 
Indigenous: A person of Aboriginal and/or Torres Strait Islander descent who identifies as 
an Aboriginal and/or Torres Strait Islander. See also Aboriginal and Torres Strait Islander. 
induction of labour: Intervention to stimulate the onset of labour. 
influenza (flu): An acute contagious viral respiratory infection marked by fevers, muscle 
aches, headache, cough and sore throat. 
intrapartum: Occurring during childbirth or during the birth process.  
ischaemic heart disease: Also heart attack and angina (chest pain). Also known as ‘coronary 
heart disease’. 
live birth: The complete expulsion or extraction from its mother of a product of conception, 
irrespective of the duration of the pregnancy, which, after such separation, breathes or shows 
any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or 
definite movement of voluntary muscles, whether or not the umbilical cord has been cut or 
the placenta is attached; each product of such a birth is considered live born (WHO 
definition). 
Marfan’s syndrome: A hereditary condition that affects the musculoskeletal system and is 
often associated with abnormalities of the cardiovascular system and the eyes. Inherited as 
an autosomal-dominant trait, Marfan’s syndrome affects men and women equally. Its major 
musculoskeletal effects include muscular underdevelopment, ligamentous laxity, joint 
hypermobility and bone elongation. 
maternal age: Mother’s age in completed years at the birth of her baby. 
maternities: In the NZ/UK, defined as the number of pregnancies that result in a live birth at 
any gestation or stillbirths occurring at or after 24 completed weeks of gestation. 
median: The midpoint of a list of observations that have been ranked from the smallest to the 
largest. 
menarche: The start of the menstrual periods and other physical and mental changes 
associated with puberty. 
morbidity: Refers to ill health in an individual and to levels of ill health in a population or 
group.  
mortality: Death. 
multipara: Pregnant woman who has had at least 1 previous pregnancy resulting in a live 
birth or stillbirth. 
neonatal death: Death of a live born baby within 28 days of birth. 
non-Indigenous: People who have declared they are not of Aboriginal or Torres Strait 
Islander descent. Compare with other Australians. 
nullipara: A women who has not given birth prior to the current pregnancy. 
obesity: Marked degree of overweight, defined for population studies as a body mass index 
of 30 or over. 
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other Australians: People who have declared they are not of Aboriginal or Torres Strait 
Islander descent, and those for whom their Indigenous status is unknown. Compare with 
non-Indigenous. 
parity: Number of previous pregnancies resulting in live births or stillbirths, excluding the 
current pregnancy. 
perinatal: Pertaining to or occurring in the period shortly before or after birth (usually up to 
28 days after). 
postnatal: Occurring after birth, with reference to the newborn.  
postpartum: Occurring after childbirth, with reference to the mother. 
psychosocial morbidity: Describes deaths in which a psychiatric condition contributed to the 
cause of death. 
puerperal psychosis: Covers a group of mental illnesses with the sudden onset of psychotic 
symptoms following childbirth. 
puerperium: The period of up to about 6 weeks after childbirth, during which the uterus 
returns to its normal size. 
rate: Is 1 number (the numerator) divided by another number (the denominator). The 
numerator is commonly the number of events in a specified time. The denominator is the 
population ‘at risk’ of the event. Rates (crude, age-specific and age-standardised) are 
generally multiplied by a number such as 100,000 to create whole numbers. 
relative risk: The relative risk compares 2 groups for their likelihood of an event. Another 
term for the relative risk is the risk ratio because it is the ratio of the risk in the ‘exposed’ 
divided by the risk in the ‘unexposed’. It is also known as the rate ratio. 
sepsis: Refers to a bacterial infection in the bloodstream or body tissues. This is a very broad 
term covering the presence of many types of microscopic disease-causing organisms. 
spontaneous vaginal birth: Birth without intervention in which the baby’s head is the 
presenting part. 
stillbirth: see fetal death (stillbirth). 
suicide: Deliberately ending one’s own life. 
tetralogy of Fallot: Congenital heart defect that is classically understood to involve 4 
anatomical abnormalities of the heart. 
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Maternal deaths in Australia 2008–2012 is the 16th report 
on women who die in association with pregnancy and 
childbirth. Maternal death review is one of the oldest  
known forms of clinical care quality assurance. Maternal 
death in Australia is a rare event in the context of worldwide 
maternal deaths. In 2008–2012, there were 105 maternal 
deaths in Australia that occurred within 42 days of the 
end of pregnancy, representing a maternal mortality ratio 
(MMR) of 7.1 deaths per 100,000 women who gave birth. 
All such deaths should be seen as devastating for the 
woman’s family and community, and should be carefully 
examined for possible lessons learned that may prevent 
future similar events.
